Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

ADC Linker

" in MCE Product Catalog:

By Targets:	ADC Antibody (2) ADC Cytotoxin (5) ADC Linker (710) Drug-Linker Conjugates for ADC (156) E3 Ligase Ligand-Linker Conjugates (1) PROTAC-Linker Conjugates for PAC (1) Amino Acid Derivatives (1) Antibody-Drug Conjugates (ADCs) (8) Apoptosis (2) Bacterial (4) CD22 (1) DNA Alkylator/Crosslinker (1) EGFR (3) Estrogen Receptor/ERR (3) Isotope-Labeled Compounds (5) MDM-2/p53 (1) Microtubule/Tubulin (19) NAMPT (1) PROTAC Linkers (212) PROTACs (2) STING (1) TAM Receptor (1) Topoisomerase (4)
By Research Areas:	Cancer (871) Cardiovascular Disease (1) Infection (4) Inflammation/Immunology (34)

By Targets:

ADC Antibody (2)

ADC Cytotoxin (5)

ADC Linker (710)

Drug-Linker Conjugates for ADC (156)

E3 Ligase Ligand-Linker Conjugates (1)

PROTAC-Linker Conjugates for PAC (1)

Amino Acid Derivatives (1)

Antibody-Drug Conjugates (ADCs) (8)

Apoptosis (2)

Bacterial (4)

CD22 (1)

DNA Alkylator/Crosslinker (1)

EGFR (3)

Estrogen Receptor/ERR (3)

Isotope-Labeled Compounds (5)

MDM-2/p53 (1)

Microtubule/Tubulin (19)

NAMPT (1)

PROTAC Linkers (212)

PROTACs (2)

STING (1)

TAM Receptor (1)

Topoisomerase (4)

By Research Areas:

Cancer (871)

Cardiovascular Disease (1)

Infection (4)

Inflammation/Immunology (34)

890

Inhibitors & Agonists

Screening Libraries

Peptides

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

Targets Recommended: ADC Linker Drug-Linker Conjugates for ADC ADC Cytotoxin ADC Antibody Target Protein Ligand-Linker Conjugates PROTAC-Linker Conjugates for PAC E3 Ligase Ligand-Linker Conjugates

Cat. No.	Product Name	Target	Research Areas

HY-126670

mDPR(Boc)-Val-Cit-PAB
ADC Linker Cancer

mDPR(Boc)-Val-Cit-PAB is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC).
HY-139441

DM21
Drug-Linker Conjugates for ADC Cancer

DM21 is a conjugate of a cleavable ADC agent and a linker (ADC linker) used in the synthesis of antibody-drug conjugates (ADCs).
HY-131833

Fmoc-Gly-Gly-Phe-OH
ADC Linker Cancer

Fmoc-Gly-Gly-Phe-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

mDPR(Boc)-Val-Cit-PAB	ADC Linker	Cancer
mDPR(Boc)-Val-Cit-PAB is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC).

DM21	Drug-Linker Conjugates for ADC	Cancer
DM21 is a conjugate of a cleavable ADC agent and a linker (ADC linker) used in the synthesis of antibody-drug conjugates (ADCs).

Fmoc-Gly-Gly-Phe-OH	ADC Linker	Cancer
Fmoc-Gly-Gly-Phe-OH is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-41541

Tetraethylene glycol monotosylate Tos-PEG4	ADC Linker PROTAC Linkers	Cancer
Tetraethylene glycol monotosylate is a cleavable and acylhydrazone-based **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Tetraethylene glycol monotosylate also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.

HY-118759

DSP Crosslinker
ADC Linker Inflammation/Immunology

DSP Crosslinker is a cleavable ADC linker, used in the synthesis of antibody-drug conjugates (ADCs).
HY-114697

DSG Crosslinker
Disuccinimidyl glutarate
ADC Linker Inflammation/Immunology

DSG Crosslinker is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-117409

Aminoethyl-SS-ethylalcohol
ADC Linker Cancer

Aminoethyl-SS-ethylalcohol is a glutathione cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-148461

Mal-VC-PAB-PNP
ADC Linker Cancer

Mal-VC-PAB-PNP is a cleavable ADC linker. Mal-VC-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs).
HY-148463

MP-Ala-Ala-PAB
ADC Linker Cancer

MP-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).
HY-148462

Fmoc-Ala-Ala-PAB
ADC Linker Cancer

Fmoc-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).
HY-148464

MC-Ala-Ala-PAB
ADC Linker Cancer

MC-Ala-Ala-PAB is a cleavable ADC linker. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).
HY-135418

Fmoc-Asp-NH2
ADC Linker Cancer

Fmoc-Asp-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-139353

Fmoc-Phe-Lys(Boc)-PAB
ADC Linker Cancer

Fmoc-Phe-Lys(Boc)-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-153328

MC-Thailanstatin A
Drug-Linker Conjugates for ADC Cancer

MC-Thailanstatin A is a drug-Linker conjugates for ADC. MC-Thailanstatin A can be used for synthesis of ADCs.

DSP Crosslinker	ADC Linker	Inflammation/Immunology
DSP Crosslinker is a cleavable **ADC linker*, used in the synthesis of antibody-drug conjugates (ADCs).*

DSG Crosslinker Disuccinimidyl glutarate	ADC Linker	Inflammation/Immunology
DSG Crosslinker is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

Aminoethyl-SS-ethylalcohol	ADC Linker	Cancer
Aminoethyl-SS-ethylalcohol is a glutathione cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

Mal-VC-PAB-PNP	ADC Linker	Cancer
Mal-VC-PAB-PNP is a cleavable **ADC linker*. Mal-VC-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs).*

MP-Ala-Ala-PAB	ADC Linker	Cancer
MP-Ala-Ala-PAB is a cleavable **ADC linker*. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).*

Fmoc-Ala-Ala-PAB	ADC Linker	Cancer
Fmoc-Ala-Ala-PAB is a cleavable **ADC linker*. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).*

MC-Ala-Ala-PAB	ADC Linker	Cancer
MC-Ala-Ala-PAB is a cleavable **ADC linker*. Fmoc-Ala-Ala-PAB can be used in the synthesis of antibody-drug conjugates (ADCs).*

Fmoc-Asp-NH2	ADC Linker	Cancer
Fmoc-Asp-NH2 is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

Fmoc-Phe-Lys(Boc)-PAB	ADC Linker	Cancer
Fmoc-Phe-Lys(Boc)-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

MC-Thailanstatin A	Drug-Linker Conjugates for ADC	Cancer
MC-Thailanstatin A is a *drug-Linker* conjugates** for ADC. MC-Thailanstatin A can be used for synthesis of ADCs.

HY-117050

PEG12-Tos	ADC Linker PROTAC Linkers	Cancer
Tos-PEG12 is a noncleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). PEG12-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-131990

MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH
ADC Linker Cancer

MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH	ADC Linker	Cancer
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-42745

m-PEG2-Tos	ADC Linker PROTAC Linkers	Cancer
m-PEG2-Tos is a uncleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG2-Tos is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-131833A

Fmoc-Gly-Gly-D-Phe-OH	ADC Linker	Cancer
Fmoc-Gly-Gly-D-Phe-OH is a cleavable **ADC linker**?used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OH is the D-isomer of Fmoc-Gly-Gly-Phe-OH (HY-131833).

HY-101157

Propargyl-PEG5-acid	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG5-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-148425

Mal-amide-PEG8-Val-Ala-PAB-PNP
ADC Linker Cancer

Mal-amide-PEG8-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Mal-amide-PEG8-Val-Ala-PAB-PNP	ADC Linker	Cancer
Mal-amide-PEG8-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-131157

Lys(MMT)-PAB-oxydiacetamide-PEG8-N3	ADC Linker	Cancer
Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 is a cleavable antibody agent conjugate linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-141597

Acid-C3-SSPy
ADC Linker Cancer

Acid-C3-SSPy is a cleavable DBA-DM4 linker used in the synthesis of DBA-DM4 (HY-128960), a agent-linker conjugate for ADC.
HY-126497

LC-PEG8-SPDP
ADC Linker Cancer

LC-PEG8-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs).

Acid-C3-SSPy	ADC Linker	Cancer
Acid-C3-SSPy is a cleavable DBA-DM4 linker used in the synthesis of DBA-DM4 (HY-128960), a agent-linker conjugate for ADC.

LC-PEG8-SPDP	ADC Linker	Cancer
LC-PEG8-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs).

HY-130818

N-(5-Hydroxypentyl)maleimide	ADC Linker	Cancer
N-(5-Hydroxypentyl)maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as Gemcitabine-O-Si(di-iso)-O-Mc (HY-130812) ).

HY-132261

AcBut
4-(4-Acetyl-phenoxy)-butyric acid
ADC Linker Cancer

AcBut is a cleavable Ozogamicin linker used in the synthesis of Ozogamicin, a agent-linker conjugate for ADC.

AcBut 4-(4-Acetyl-phenoxy)-butyric acid	ADC Linker	Cancer
AcBut is a cleavable Ozogamicin linker used in the synthesis of Ozogamicin, a agent-linker conjugate for ADC.

HY-126886

Mal-PEG1-NHS ester	ADC Linker PROTAC Linkers	Cancer
Mal-PEG1-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG1-NHS ester is PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130144

Ald-CH2-PEG3-azide	ADC Linker PROTAC Linkers	Cancer
Ald-CH2-PEG3-azide is a cleavable 3 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Ald-CH2-PEG3-azide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-117519

Amino-Tri-(carboxyethoxymethyl)-methane	ADC Linker PROTAC Linkers	Cancer
Amino-Tri-(carboxyethoxymethyl)-methane is a cleavable PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(carboxyethoxymethyl)-methan is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-148871

Mc-Val-Cit-PAB-Gefitinib chloride	Drug-Linker Conjugates for ADC	Cancer
Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB.

HY-W101718

Fmoc-N-(2-Boc-aminoethyl)-Gly-OH	Isotope-Labeled Compounds ADC Linker	Cancer
Fmoc-N-(2-Boc-aminoethyl)-Gly-OH is a Fmoc-protected glycine derivative that can be used in antibody agent coupling (ADC) synthesis. ADC consists of antibodies that are linked to ADC cytotoxins via ADC junctions[1].

HY-140454

Azido-PEG8-acid	ADC Linker PROTAC Linkers	Cancer
Azido-PEG8-acid is a non-cleavable 8 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-140501

m-PEG11-acid	ADC Linker PROTAC Linkers	Cancer
m-PEG11-acid is a non-cleavable 11 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG11-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-140500

m-PEG10-acid	ADC Linker PROTAC Linkers	Cancer
m-PEG10-acid is a non-cleavable 10 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG10-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130222

Mal-PEG2-Val-Cit-PAB-OH	ADC Linker PROTAC Linkers	Cancer
Mal-PEG2-Val-Cit-PAB-OH is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-Val-Cit-PAB-OH also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.

HY-141395

m-PEG4-Boc	ADC Linker PROTAC Linkers	Cancer
m-PEG4-Boc is a cleavable 4 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG4-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130315

Br-PEG4-C2-Boc
ADC Linker PROTAC Linkers Cancer

Br-PEG4-C2-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Br-PEG4-C2-Boc	ADC Linker PROTAC Linkers	Cancer
Br-PEG4-C2-Boc is a cleavable 4 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-140215

Azido-PEG6-amine	PROTAC Linkers ADC Linker	Cancer
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azido-PEG6-amine is also a non-cleavable 6 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-140226

m-PEG10-amine	ADC Linker PROTAC Linkers	Cancer
m-PEG10-amine is a non-cleavable 10 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG10-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-126951

Aminooxy-PEG2-alcohol	ADC Linker PROTAC Linkers	Cancer
Aminooxy-PEG2-alcohol is a non-cleavable 2 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Aminooxy-PEG2-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-140004

Azide-PEG3-Tos	PROTAC Linkers ADC Linker	Cancer
Azide-PEG3-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azide-PEG3-Tos is also a non-cleavable 3 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-113931

Aminooxy-PEG2-azide	PROTAC Linkers ADC Linker	Cancer
Aminooxy-PEG2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Aminooxy-PEG2-azide is also a non-cleavable 2 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130211

Azido-PEG5-alcohol	ADC Linker PROTAC Linkers	Cancer
Azido-PEG5-alcohol is a non-cleavable 5 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-141220

m-PEG12-OH	PROTAC Linkers ADC Linker	Cancer
m-PEG12-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. m-PEG12-OH is also a non-cleavable 12 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-140227

m-PEG12-amine	PROTAC Linkers ADC Linker	Cancer
m-PEG12-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. m-PEG12-amine is also a non-cleavable 12 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-124123

Aminooxy-PEG4-alcohol	ADC Linker PROTAC Linkers	Cancer
Aminooxy-PEG4-alcohol is a non-cleavable 4 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Aminooxy-PEG4-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-132252

Mal-PEG8-Val-Ala-PABC
ADC Linker Cancer

Mal-PEG8-Val-Ala-PABC is a cleavable Tesirine linker used in the synthesis of Tesirine, a agent-linker conjugate for ADC.

Mal-PEG8-Val-Ala-PABC	ADC Linker	Cancer
Mal-PEG8-Val-Ala-PABC is a cleavable Tesirine linker used in the synthesis of Tesirine, a agent-linker conjugate for ADC.

HY-130293

Propargyl-PEG4-CH2CH2-Boc	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG4-CH2CH2-Boc is a non-cleavable **ADC linker** that can be used to synthesize ADC inhibitors of Galectin-3. Propargyl-PEG4-CH2CH2-Boc is a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-150043A

MDTF
ADC Linker Cancer

MDTF is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-117519A

Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride	ADC Linker PROTAC Linkers	Cancer
Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride is a cleavable PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(carboxyethoxymethyl)-methan hydrochloride is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-23641

NH-bis(C1-Boc)
ADC Linker Cancer

NH-bis(C1-Boc)is a uncleavable linker used for antibody-drug conjugates (ADC).

HY-140150

Azido-PEG3-Val-Cit-PAB-PNP	ADC Linker PROTAC Linkers	Cancer
Azido-PEG3-Val-Cit-PAB-PNP is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG3-Val-Cit-PAB-PNP is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-140149

Azido-PEG4-Val-Cit-PAB-OH	ADC Linker PROTAC Linkers	Cancer
Azido-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-Val-Cit-PAB-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-126949

Aminooxy-PEG3-azide	ADC Linker PROTAC Linkers	Cancer
Aminooxy-PEG3-azide is a non-cleavable 3 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Aminooxy-C2-PEG3-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-141218

m-PEG10-alcohol Decaethylene glycol monomethyl ether	ADC Linker PROTAC Linkers	Cancer
m-PEG10-alcohol (Decaethylene glycol monomethyl ether) is a non-cleavable 10 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG10-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130161

m-PEG4-Br	ADC Linker PROTAC Linkers	Cancer
m-PEG4-Br is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab (HY-P9907). m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in vitro potency. m-PEG4-Br also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.

HY-W039178

Hydroxy-PEG4-(CH2)2-Boc	ADC Linker PROTAC Linkers	Cancer
Hydroxy-PEG4-(CH2)2-Boc is a uncleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191). Hydroxy-PEG4-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.

HY-42488

Hydroxy-PEG3-(CH2)2-Boc	ADC Linker PROTAC Linkers	Cancer
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196). Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.

HY-131955

Fmoc-aminooxy-PEG2-NH2
ADC Linker Cancer

Fmoc-aminooxy-PEG2-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-150043

MDTF free acid
ADC Linker Cancer

MDTF free acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W067061

Hydroxy-PEG2-(CH2)2-Boc	ADC Linker PROTAC Linkers	Cancer
Hydroxy-PEG2-(CH2)2-Boc is a uncleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196). Hydroxy-PEG2-(CH2)2-Boc is also a PROTAC linker that can be used in the synthesis of PROTACs.

HY-130442

Mal-PEG2-acid	ADC Linker PROTAC Linkers	Cancer
Mal-PEG2-acid is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-acid can be conjugated to Tubulysin (HY-128914) and its derivative cytotoxic molecule. Mal-PEG2-acid is also a PROTAC linker that can be used in the synthesis of PROTACs.

HY-126513

Propargyl-PEG1-NHS ester
ADC Linker Cancer

Propargyl-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
HY-126516

Propargyl-PEG4-NHS ester
ADC Linker Cancer

Propargyl-PEG4-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).

HY-118764

Propargyl-PEG2-acid	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG2-acid is a non-cleavable 2 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-117104

Hydroxy-PEG4-acid	ADC Linker PROTAC Linkers	Cancer
Hydroxy-PEG4-acid is a non-cleavable 4 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-147286A

Ac-Lys-Val-Cit-PABC-MMAE formic	Drug-Linker Conjugates for ADC	Cancer
Ac-Lys-Val-Cit-PABC-MMAE (formic) is a agent-linker conjugate for ADC. Ac-Lys-Val-Cit-PABC-MMAE contains the **ADC linker (peptide Ac-Lys-Val-Cit-PABC) and a potent tubulin** polymerization inhibitor Monomethyl auristatin E (HY-15162).

HY-21577

Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine	ADC Linker PROTAC Linkers	Cancer
Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is a cleavable PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane is also a PEG/Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130426

Maleimido-tri(ethylene glycol)-propionic acid Mal-PEG3-acid	ADC Linker PROTAC Linkers	Cancer
Maleimido-tri(ethylene glycol)-propionic acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Maleimido-tri(ethylene glycol)-propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation. Maleimido-tri(ethylene glycol)-propionic acid also can be used as a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130537

Azido-PEG6-alcohol	PROTAC Linkers ADC Linker	Cancer
Azido-PEG6-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azido-PEG6-alcohol is also a non-cleavable 6 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130474

Azido-PEG6-NHS ester	ADC Linker PROTAC Linkers	Cancer
Azido-PEG6-NHS ester is a cleavable 6 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130184

Azido-PEG8-NHS ester	ADC Linker PROTAC Linkers	Cancer
Azido-PEG8-NHS ester is a cleavable 8 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG8-NHS ester is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130194

Azido-PEG5-CH2CO2H	ADC Linker PROTAC Linkers	Cancer
Azido-PEG5-CH2CO2H is a cleavable 5 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG5-CH2CO2H is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-145951

Amidate-VC-PAB-MMAF	Drug-Linker Conjugates for ADC	Cancer
Amidate-VC-PAB-MMAF consists a cleavable ADC linker (Amidate-VC-PAB) and a potent tubulin polymerization inhibitor (MMAF). Amidate-VC-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs). Amidate-VC-PAB-MMAF reduces off-target cytotoxicity of ADCs.

HY-42618

Azido-PEG4-CH2-Boc	ADC Linker PROTAC Linkers	Cancer
Azido-PEG4-CH2-Boc is a cleavable 4 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG4-CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-148245

OH-Glu-Val-Cit-PAB-MMAE	ADC Linker	Cancer
OH-Glu-Val-Cit-PAB-MMAE consists a cleavable **ADC linker** (OH-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-126505

Mal-PEG4-NHS ester
ADC Linker Cancer

Mal-PEG4-NHS ester is a non-cleavable ADC linker which links Quantum dots (QDs) with PEGylated liposomes.

HY-126894

Bis-PEG9-acid	PROTAC Linkers ADC Linker	Cancer
Bis-?PEG9-?acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-?PEG9-?acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126893

Bis-PEG8-acid	PROTAC Linkers ADC Linker	Cancer
Bis-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG8-acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-111012

DBCO-(PEG)3-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
DBCO-(PEG)3-VC-PAB-MMAE is a agent-linker conjugate for ADC. DBCO-(PEG)3-VC-PAB-MMAE is made by Monomethyl auristatin E (HY-15162) conjugats to DBCO-(PEG)3-vc-PAB linker. DBCO-(PEG)3-VC-PAB-MMAE can be used for the research of cancer.

HY-126892

Bis-PEG7-acid	PROTAC Linkers ADC Linker	Cancer
Bis-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-propionic acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-42489

N3-PEG3-CH2CH2-Boc	ADC Linker PROTAC Linkers	Cancer
N3-PEG3-CH2CH2-Boc is a cleavable 3 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). N3-PEG3-CH2CH2-Boc is also a PEG- and Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130408

m-PEG6-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG6-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG6-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W018174

m-PEG3-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-140310

TCO-PEG4-DBCO	ADC Linker PROTAC Linkers	Cancer
TCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-DBCO is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130410

Bis-PEG6-NHS ester	ADC Linker PROTAC Linkers	Cancer
Bis-PEG6-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130387

Propargyl-PEG4-Tos	PROTAC Linkers ADC Linker	Cancer
Propargyl-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Tos is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126885

DBCO-PEG5-NHS ester	ADC Linker PROTAC Linkers	Cancer
DBCO-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG5-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-147093

vc-PAB-DMEA-PNU159682	ADC Linker	Cancer
vc-PAB-DMEA-PNU159682 (compound I.47) can be used to synthesize the ADC molecule based on Sulfomaleimide-based Linker. vc-PAB-DMEA-PNU159682 has good serum stability.

HY-147094

vc-PABC-DM1
ADC Linker Cancer

vc-PABC-DM1 used to synthesize an ADC molecule based on utilize disulfide linker. vc-PABC-DM1 can be used to explore serum stability.

HY-147021

MC-Val-D-Cit-PAB-PNP	ADC Linker	Cancer
MC-Val-D-Cit-PAB-PNP is a cleavable peptide linker molecule used in the synthesis of antibody-drug conjugates (ADCs). MC-Val-D-Cit-PAB-PNP contains a maleimidocaproyl (Mc) group that can be conjugated to an antibody and a p-nitrophenol (PNP) group that allows the peptide to be linked to antitumor compounds.

HY-W019939

Hydroxy-PEG10-Boc	ADC Linker	Cancer
Hydroxy-PEG10-Boc is extacted from patent CN108707228 (example 0024). Hydroxy-PEG10-Boc is a uncleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel (HY-B0015) or docetaxel (HY-B0011).

HY-118808

Propargyl-PEG2-NHBoc	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG2-NHBoc is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-NHBoc is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-126976

Propargyl-PEG5-amine	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG5-amine is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-W051634

Propargyl-PEG2-amine	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG2-amine is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG2-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-126677

Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA	ADC Linker PROTAC Linkers	Cancer
Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA is a double claevable 3-unit and 4-unit PEG linker for antibody-agent-conjugation (ADC). Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA also is a PROTAC linker that can be used in the synthesis of PROTACs.

HY-129589

Thailanstatin A	ADC Cytotoxin	Cancer
Thailanstatin A is an ultra-potent inhibitor of eukaryotic RNA splicing (IC₅₀=650 nM). Thailanstatin A exerts effects via non-covalent binding to the SF3b subunit of the U2 snRNA subcomplex of the spliceosome and shows low-nM to sub-nM IC₅₀s against multiple cancer cell lines. Thailanstatin A, a payload for ADCs, is conjugated to the lysines on trastuzumab yielding “linker-less” ADC.

HY-145399

Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a conjugate used to synthesis ADC. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan comprises topoisomerase inhibitor derivative with a linker for connecting to a ligand unit (extracted from patent US20200306243A1).

HY-44221

MAC glucuronide linker-1
ADC Linker Cancer

MAC glucuronide linker-1 is a claevable ADC linker for antibody-agent-conjugations (ADCs).
HY-44222

MAC glucuronide linker-2
ADC Linker Cancer

MAC glucuronide linker-2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-145736A

β-Glucuronide-dPBD-PEG5-NH2 TFA	Drug-Linker Conjugates for ADC Apoptosis	Cancer
β-Glucuronide-dPBD-PEG5-NH2 TFA is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD.β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2 TFA, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 TFA can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 TFA has antitumor activity.

HY-145736

β-Glucuronide-dPBD-PEG5-NH2	Drug-Linker Conjugates for ADC Apoptosis	Cancer
β-Glucuronide-dPBD-PEG5-NH2 is the β-glucuronide-linked pyrrolobenzodiazepine dimer, which binds to the prenylated antibody for synthesis of antibody-drug conjugate (ADC) cIRCR201-dPBD. β-glucuronide-linkage as a cleavable linker. β-Glucuronide-dPBD-PEG5-NH2, as a proagent of cIRCR201-dPBD, reduces side effects. β-Glucuronide-dPBD-PEG5-NH2 can induce apoptosis and arrest cell cycle. β-Glucuronide-dPBD-PEG5-NH2 has antitumor activity.

HY-130810

DBCO-Sulfo-Link-biotin
ADC Linker Cancer

DBCO-Sulfo-Link-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-104025

SPB	Drug-Linker Conjugates for ADC	Inflammation/Immunology
SPB is a agent-linker conjugate for ADC with potent anti-inflammatory activity by using Xanthotoxol, linked via the ADC linker.

HY-128959

MCC-Modified Daunorubicinol	Drug-Linker Conjugates for ADC	Cancer
Daunorubicinol is a agent-linker conjugate for ADC with potent antitumor activity by using Aur0101 (DNA Topoisomerase II inhibitor), linked via the ADC linker.

HY-129369

SPDMB
ADC Linker Cancer

SPDMB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
HY-12448

SPDB
ADC Linker Cancer

SPDB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
HY-129368

SPDMV
ADC Linker Cancer

SPDMV is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
HY-136095

Tetrazine-biotin
ADC Linker Cancer

Tetrazine-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130111

DMAC-SPP
ADC Linker Cancer

DMAC-SPP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140014

Val-Cit
ADC Linker Cancer

Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-101151

sulfo-SPDB
ADC Linker Cancer

sulfo-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-128970

Mp-polymer ester
Drug-Linker Conjugates for ADC Cancer

Mp-polymer ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-116270

DBCO-Maleimide
ADC Linker Cancer

DBCO-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126349

DTSSP Crosslinker
ADC Linker Cancer

DTSSP Crosslinker is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140098

Boc-Cystamine
ADC Linker Cancer

Boc-Cystamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-42973

DBCO-NHS ester
ADC Linker Cancer

DBCO-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133550

DMAC-SPDB
ADC Linker Cancer

DMAC-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-79584

Propargyl-Tos
ADC Linker Cancer

Propargyl-Tos is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126405

SMPT
ADC Linker Cancer

SMPT is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133542

Dimethylamine-SPDB
ADC Linker Cancer

Dimethylamine-SPDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126531

DMAC-PDB
ADC Linker Cancer

DMAC-PDB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136104

Methyltetrazine-Maleimide
ADC Linker Cancer

Methyltetrazine-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W000423

DBCO-amine
ADC Linker Cancer

DBCO-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W071006

PPC-NHS ester 2,5-Dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate	ADC Linker	Cancer
PPC-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133543

SPDP-sulfo
ADC Linker Cancer

SPDP-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136033

Methyltetrazine-SS-NHS
ADC Linker Cancer

Methyltetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140987

5-Maleimidovaleric acid
ADC Linker Cancer

5-Maleimidovaleric acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140313

Methyltetrazine-DBCO
ADC Linker Cancer

Methyltetrazine-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130110

Sulfo-DMAC-SPP
ADC Linker Cancer

Sulfo-DMAC-SPP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140306

Mal-Sulfo-DBCO
ADC Linker Cancer

Mal-Sulfo-DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W019543

DSS Crosslinker
ADC Linker Cancer

DSS Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-147118

NHS-SS-Ph
ADC Linker Cancer

NHS-SS-Ph is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140105

Azidoethyl-SS-ethylazide
ADC Linker Cancer

Azidoethyl-SS-ethylazide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141158

N-(Iodoacetamido)-Doxorubicin
ADC Linker Cancer

N-(Iodoacetamido)-Doxorubicin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136031

Tetrazine-SS-Biotin
ADC Linker Cancer

Tetrazine-SS-Biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140100

Azidoethyl-SS-propionic acid
ADC Linker Cancer

Azidoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140296

BDP FL DBCO
ADC Linker Cancer

BDP FL DBCO is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138327

1,6-Bis(mesyloxy)hexane
ADC Linker Cancer

16-Bismesyloxyhexane is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135973

BCN-SS-NHS
ADC Linker Cancer

BCN-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136032

Tetrazine-SS-NHS
ADC Linker Cancer

Tetrazine-SS-NHS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135978

DBCO-SS-amine
ADC Linker Cancer

DBCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135972

BCN-SS-amine
ADC Linker Cancer

BCN-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140096

Aminoethyl-SS-propionic acid
ADC Linker Cancer

Aminoethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126851

Fluorescein-DBCO
ADC Linker Cancer

Fluorescein-DBCO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126518

Cyclooctyne-O-PFP ester
ADC Linker Cancer

Cyclooctyne-O-PFP ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W096127

Biotin-sar-oh
ADC Linker Cancer

Biotin-sar-oh is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130928

Tetrazine-Ph-OPSS
ADC Linker Cancer

Tetrazine-Ph-OPSS is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140122

THP-SS-alcohol
ADC Linker Cancer

THP-SS-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-123687

DBCO-Sulfo-NHS ester sodium
ADC Linker Cancer

DBCO-Sulfo-NHS ester sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140104

Azidoethyl-SS-ethylamine
ADC Linker Cancer

Azidoethyl-SS-ethylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138506

DBCO-S-S-acid
ADC Linker Cancer

DBCO-S-S-acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-129360

Ala-Ala-Asn-PAB
ADC Linker Cancer

Ala-Ala-Asn-PAB is a peptide cleavable ADC linker for antibody-drug conjugates (ADCs).
HY-126517

Cyclooctyne-O-NHS ester
ADC Linker Cancer

Cyclooctyne-O-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135977

DBCO-SS-aldehyde
ADC Linker Cancer

DBCO-SS-aldehyde is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-131084

DMAC-SPDB-sulfo
ADC Linker Cancer

DMAC-SPDB-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W011541

SIA Crosslinker
ADC Linker Cancer

SIA Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W002213

N-Hydroxysulfosuccinimide sodium
ADC Linker Cancer

N-Hydroxysulfosuccinimide (sodium) is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140129

NHS-SS-biotin
ADC Linker Cancer

NHS-SS-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136039

TCO-SS-amine
ADC Linker Cancer

TCO-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-15742

Vc-MMAD	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
Vc-MMAD consists the ADCs linker (Val-Cit) and potent tubulin inhibitor (MMAD). Vc-MMAD is a agent-linker conjugate for ADC.

HY-148194

SC239
ADC Linker Cancer

SC239 is a cleavable 2-aminophenyl hemiasterlin agent-linker. SC239 can be as the agent-linker for ADC.

HY-130112

N-Succinimidyloxycarbonylpropyl methanethiosulfonate NHS-C4-MTS	ADC Linker	Cancer
N-Succinimidyloxycarbonylpropyl methanethiosulfonate is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-124329

BS3 Crosslinker
ADC Linker Cancer

BS3 Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130935

DBCO-Val-Cit-OH
ADC Linker Cancer

DBCO-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-101153

MC-Val-Ala-OH
ADC Linker Cancer

MC-Val-Ala-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126364

Mc-Val-Ala-PAB
ADC Linker Cancer

Mc-?Val-?Ala-?PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140138

PC SPDP-NHS carbonate ester
ADC Linker Cancer

PC SPDP-NHS carbonate ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W097109A

Fmoc-(D-Phe)-OSu
ADC Linker Cancer

Fmoc-(D-Phe)-Osu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136102

Py-ds-Prp-Osu
ADC Linker Cancer

Py-ds-Prp-Osu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140102

Azidoethyl-SS-propionic NHS ester
ADC Linker Cancer

Azidoethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W023121

Fmoc-Gly-Gly-OH
ADC Linker Cancer

Fmoc-Gly-Gly-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141141

Boc-Val-Cit-PAB
ADC Linker Cancer

Boc-Val-Cit-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140140

PC Mal-NHS carbonate ester
ADC Linker Cancer

PC Mal-NHS carbonate ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138322

N-trifluoroacetyl-β-alanyl chloride
ADC Linker Cancer

N-trifluoroacetyl-β-alanyl chloride is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-129362

Phe-Lys(Fmoc)-PAB
ADC Linker Cancer

Phe-Lys(Fmoc)-PAB is a cathepsin cleavable ADC linker used for the antibody-drug conjugates (ADCs).
HY-129360A

Ala-Ala-Asn-PAB TFA
ADC Linker Cancer

Ala-Ala-Asn-PAB TFA is a peptide cleavable ADC linker for antibody-drug conjugates (ADCs).
HY-138387

6-Azido-hexylamine
ADC Linker Cancer

6-Azido-hexylamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-129349

Phe-Lys(Trt)-PAB
ADC Linker Cancer

Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used for the antibody-drug conjugates (ADCs).
HY-W038702

Boc-Val-Cit-OH
ADC Linker Cancer

Boc-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133504

Tetrazine-Ph-SS-amine
ADC Linker Cancer

Tetrazine-Ph-SS-amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W044078

N-Boc-diethanolamine	ADC Linker PROTAC Linkers	Cancer
N-Boc-diethanolamine is an Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-diethanolamine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-42146

BMPS
ADC Linker Cancer

BMPS is a nonclaevable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-128896

Nitro-PDS-Tubulysin M	Drug-Linker Conjugates for ADC	Cancer
Nitro-PDS-Tubulysin M is a agent-linker conjugate for ADC with potent antitumor activity by using Tubulysin M (a tubulin polymerization inhibitor), linked via the ADC linker Nitro-PDS.

HY-126353

Fmoc-Val-Ala-PAB-OH
ADC Linker Cancer

Fmoc-Val-Ala-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-44234

Fmoc-Gly-Gly-Phe-OtBu
ADC Linker Cancer

Fmoc-Gly-Gly-Phe-OtBu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140116

Boc-NH-ethyl-SS-propionic acid
ADC Linker Cancer

Boc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-124329A

BS3 Crosslinker disodium
ADC Linker Cancer

BS3 Crosslinker disodium is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130937

DBCO-Val-Cit-PABC-PNP
ADC Linker Cancer

DBCO-Val-Cit-PABC-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133412

DBCO-NHCO-S-S-NHS ester
ADC Linker Cancer

DBCO-NHCO-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130961

Boc-Val-Dil-Dap-OH
ADC Linker Cancer

Boc-Val-Dil-Dap-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130936

DBCO-Val-Cit-PABC-OH
ADC Linker Cancer

DBCO-Val-Cit-PABC-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141145

OPSS-Val-Cit-PAB-PNP
ADC Linker Cancer

OPSS-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130932

Boc-Val-Ala-PAB-PNP
ADC Linker Cancer

Boc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136136

Fmoc-Val-Ala-PAB-PNP
ADC Linker Cancer

Fmoc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140118

Fmoc-NH-ethyl-SS-propionic acid
ADC Linker Cancer

Fmoc-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133413

DBCO-CONH-S-S-NHS ester
ADC Linker Cancer

DBCO-CONH-S-S-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141144

OPSS-Val-Cit-PAB-OH
ADC Linker Cancer

OPSS-Val-Cit-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141142

Boc-Val-Cit-PAB-PNP
ADC Linker Cancer

Boc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140117

Boc-aminooxy-ethyl-SS-propanol
ADC Linker Cancer

Boc-aminooxy-ethyl-SS-propanol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130930

Acid-propionylamino-Val-Cit-OH
ADC Linker Cancer

Acid-propionylamino-Val-Cit-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140120

Mal-NH-ethyl-SS-propionic acid
ADC Linker Cancer

Mal-NH-ethyl-SS-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140125

2-Hydroxyethyl disulfide mono-tosylate
ADC Linker Cancer

2-Hydroxyethyl disulfide mono-tosylate is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136139

3-Azidopropionic Acid Sulfo-NHS ester
ADC Linker Cancer

3-Azidopropionic Acid Sulfo-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136107

Fmoc-Phe-Lys(Trt)-PAB
ADC Linker Cancer

Fmoc-Phe-Lys(Trt)-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135975

MC-Val-Ala-PAB-PNP
ADC Linker Cancer

MC-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W071007

NO2-SPDMV
ADC Linker Cancer

NO2-SPDMV is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-139856

Mal-Ala-Ala-PAB-PNP
ADC Linker Cancer

Mal-Ala-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136317

MC-betaglucuronide-MMAE-1	Drug-Linker Conjugates for ADC	Cancer
MC-betaglucuronide-MMAE-1 is a agent-linker conjugate for ADC with potent antitumor activity by using MMAE (a tubulin polymerization inhibitor), linked via the cleavable ADC linker MC-betaglucuronide.

HY-136321

MC-betaglucuronide-MMAE-2	Drug-Linker Conjugates for ADC	Cancer
MC-betaglucuronide-MMAE-2 is a agent-linker conjugate for ADC with potent antitumor activity by using MMAE (a tubulin polymerization inhibitor), linked via the cleavable ADC linker MC-betaglucuronide.

HY-126692

Mal-VC-PAB-ABAEP-Azonafide	Drug-Linker Conjugates for ADC	Cancer
Mal-VC-PAB-ABAEP-Azonafide is a agent-linker conjugate for ADC with with potent antitumor activity by using Azonafide (a cytotoxin), linked via the ADC linker Mal-VC-PAB.

HY-128906

MC-Val-Cit-PAB-Retapamulin	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-Retapamulin is a agent-linker conjugate for ADC with potent antitumor activity by using Retapamulin (a ribosome inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

HY-136287

DBM-MMAF	Drug-Linker Conjugates for ADC	Cancer
DBM-MMAF is a agent-linker conjugate composed of a potent antitubulin agent MMAF and a linker DBM to make antibody agent conjugate (ADC).

HY-129366

PDB-Pfp
ADC Linker Cancer

PDB-Pfp is a cleavable ADC linker?used in the synthesis of antibody-drug conjugates (ADCs).
HY-144554

Aminooxy CatB-LXR
Drug-Linker Conjugates for ADC Cancer

Aminooxy CatB-LXR (compound 10) is a agent-linker conjugates for ADC.
HY-129373

SPDMV-sulfo
ADC Linker Cancer

SPDMV-sulfo is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
HY-126667

SC-Val-Cit-PAB
ADC Linker Cancer

SC-Val-Cit-PAB is a cleavable ADC linker for antibody-drug conjugates (ADCs).

HY-128907

MC-Val-Cit-PAB-clindamycin	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-clindamycin is a agent-linker conjugate for ADC with potent antitumor activity by using clindamycin (a protein synthesis inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

HY-128957

Vc-seco-DUBA SYD985	Drug-Linker Conjugates for ADC	Cancer
Vc-seco-DUBA (SYD985) is a agent-linker conjugate for ADC with potent antitumor activity by using DUBA (DNA alkylating agent), linked via the ADC linker Vc-seco.

HY-128902

MC-Val-Cit-PAB-vinblastine	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-vinblastine is a agent-linker conjugate for ADC with potent antitumor activity by using vinblastine (an microtubule protein inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

HY-126491

SPP-DM1	Drug-Linker Conjugates for ADC	Cancer
SPP-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPP.

HY-W040236

m-PEG8-Amine
ADC Linker PROTAC Linkers Cancer

m-PEG8-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133547

NO2-SPP-sulfo
ADC Linker Cancer

NO2-SPP-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133548

NO2-SPDB-sulfo
ADC Linker Cancer

NO2-SPDB-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-78921

Fmoc-3VVD-OH
ADC Linker Cancer

Fmoc-3VVD-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130976

N-Boc-Val-Dil-Dap-Doe
ADC Linker Cancer

N-Boc-Val-Dil-Dap-Doe is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136132

MC-VC-PAB-NH2
ADC Linker Cancer

MC-VC-PAB-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136547

Boc-Val-Ala-PAB
ADC Linker Others

Boc-Val-Ala-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate (ADCs).
HY-129350

Fmoc-Phe-Lys(Trt)-PAB-PNP
ADC Linker Cancer

Fmoc-Phe-Lys(Trt)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130547

BS2G Crosslinker disodium
ADC Linker Cancer

BS2G Crosslinker (disodium) is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136125

BCOT-PEF3-OPFP
ADC Linker Cancer

BCOT-PEF3-OPFP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133549

NO2-SPDMV-sulfo
ADC Linker Cancer

NO2-SPDMV-sulfo is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138521

Azido-C6-OH
ADC Linker Cancer

Azido-C6-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130975

Boc-Val-Dil-Dap-Phe-OMe
ADC Linker Cancer

Boc-Val-Dil-Dap-Phe-OMe is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140119

Fmoc-NH-ethyl-SS-propionic NHS ester
ADC Linker Cancer

Fmoc-NH-ethyl-SS-propionic NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-120770

DBCO-PEG4-Maleimide
ADC Linker Cancer

DBCO-PEG4-Maleimide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130933

Fmoc-Ala-Ala-Asn(Trt)-OH
ADC Linker Cancer

Fmoc-Ala-Ala-Asn(Trt)-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138535

Azide-C2-Azide
ADC Linker Cancer

Azide-C2-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126502

Mal-C2-NHS ester
ADC Linker Cancer

Mal-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136329

β-D-glucuronide-pNP-carbonate
ADC Linker Cancer

β-D-glucuronide-pNP-carbonate is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-116063

Doxorubicin-SMCC	Drug-Linker Conjugates for ADC	Cancer
Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin.

HY-130383

Propargyl-PEG7-acid	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130386

Propargyl-PEG6-acid	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG6-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-136289

MB-VC-MGBA	Drug-Linker Conjugates for ADC	Cancer
MB-VC-MGBA is a agent-linker conjugate for ADC with potent antitumor activity by using MGBA (minor-groove-binding DNA-alkylating agent), linked via the ADC linker MB-VC.

HY-128903

MC-Val-Cit-PAB-carfilzomib iodide	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-carfilzomib iodide is a agent-linker conjugate for ADC with potent antitumor activity by using carfilzomib (an irreversible proteasome inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

HY-136316

MC-VC-PAB-MMAD	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
MC-VC-PAB-MMAD is a agent-linker conjugate for ADC with potent antitumor activity by using MMAD (a potent tubulin inhibitor), linked via the cleavable ADC linker MC-VC-PAB.

HY-136315

OSu-Glu-VC-PAB-MMAD	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
OSu-Glu-VC-PAB-MMAD is a agent-linker conjugate for ADC with potent antitumor activity by using MMAD (a potent tubulin inhibitor), linked via the cleavable ADC linker OSu-Glu-VC-PAB.

HY-128955

MC-VC-PABC-Aur0101	Drug-Linker Conjugates for ADC	Cancer
MC-VC-PABC-Aur0101 is a agent-linker conjugate for ADC with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the ADC linker MC-VC-PABC.

HY-128893

MC-Sq-Cit-PAB-Gefitinib	Drug-Linker Conjugates for ADC	Cancer
MC-Sq-Cit-PAB-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using Gefitinib (an EGFR tyrosine kinase inhibitor), linked via the ADC linker MC-Sq-Cit-PAB.

HY-126530

PPC-NB
ADC Linker Cancer Cardiovascular Disease

PPC-NB is a glutathione cleavable linker used for the antibody-drug conjugate (ADC).

HY-133540

Maleimide-DOTA Maleimido-mono-amide-DOTA	ADC Linker	Cancer Inflammation/Immunology
Maleimide-DOTA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-148399

Mal-VC-PAB-PNP-CDN-A
Drug-Linker Conjugates for ADC Cancer

Mal-VC-PAB-PNP-CDN-A is a agent-linker conjugate for ADC.
HY-129370

SPDB-sulfo
ADC Linker Cancer

SPDB-sulfo is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs) .
HY-136154

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP
ADC Linker Cancer

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141143

MC(C5)-Val-Cit
ADC Linker Cancer

MC(C5)-Val-Cit is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126495A

Sulfo-SPDP-C6-NHS sodium
ADC Linker Cancer

Sulfo-SPDP-C6-NHS sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-145488

MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D	ADC Linker	Cancer
MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133584

Bis-SS-C3-NHS ester
ADC Linker Cancer

Bis-SS-C3-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-145593

Aminooxy-PEG2-BCN
ADC Linker Cancer

Aminooxy-PEG2-BCN is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140126

Bis-Tos-(2-hydroxyethyl disulfide)
ADC Linker Cancer

Bis-Tos-(2-hydroxyethyl disulfide) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130166

Amino-PEG9-acid	ADC Linker PROTAC Linkers	Cancer
Amino-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG9-acid is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W034595

Eicosanedioic acid	ADC Linker PROTAC Linkers	Cancer
Eicosanedioic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Eicosanedioic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis

HY-W591438

Mc-Phe-Lys(Boc)-PAB
ADC Linker Others

Mc-Phe-Lys(Boc)-PAB is an ADC linker.

HY-130812

Gemcitabine-O-Si(di-iso)-O-Mc	Drug-Linker Conjugates for ADC	Cancer
Gemcitabine-O-Si(di-iso)-O-Mc is a agent-linker conjugate for ADC with potent antitumor activity by using Gemcitabine (a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent; HY-17026), linked via the ADC linker.

HY-128908

MC-Val-Cit-PAB-Indibulin	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.

HY-128899

MC-Val-Cit-PAB-Auristatin E	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-Auristatin E is a agent-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker MC-Val-Cit-PAB.

HY-126492

Vat-Cit-PAB-Monomethyl Dolastatin 10	Drug-Linker Conjugates for ADC	Cancer
Vat-Cit-PAB-Monomethyl Dolastatin 10 is a agent-linker conjugate for ADC with potent antitumor activity by using Monomethyl Dolastatin 10 (a potent tubulin inhibitor), linked via the ADC linker Vat-Cit-PAB.

HY-128897

MC-VC-PABC-DNA31	Drug-Linker Conjugates for ADC	Cancer
MC-VC-PABC-DNA31 is a agent-linker conjugate for ADC with potent antitumor activity by using DNA31 (a potent RNA polymerase inhibitor), linked via the ADC linker MC-VC-PABC.

HY-145989

Aminobenzenesulfonic auristatin E	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
Aminobenzenesulfonic auristatin E is a agent-linker conjugate for ADC. Aminobenzenesulfonic auristatin E has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic.

HY-128909

MC-Val-Cit-PAB-rifabutin	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-rifabutin is a agent-linker conjugate for ADC with potent antitumor activity by using rifabutin (an DNA-dependent RNA polymerase inhibitor), linked via the ADC linker MC-Val-Cit-PAB.

HY-136320

MC-VC-PABC-SP 141	Drug-Linker Conjugates for ADC MDM-2/p53	Cancer
MC-VC-PABC-SP 141 is a agent-linker conjugate for ADC with potent antitumor activity by using SP 141 (a potent MDM2 inhibitor), linked via the cleavable ADC linker MC-VC-PABC.

HY-130528

m-PEG7-Ms	ADC Linker PROTAC Linkers	Cancer
m-PEG7-Ms is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Ms is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-141170

TCO-PEG12-NHS ester	ADC Linker PROTAC Linkers	Cancer
TCO-PEG12-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG12-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130457

m-PEG4-Ms	ADC Linker PROTAC Linkers	Cancer
m-PEG4-Ms is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Ms is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-120237

m-PEG7-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG7-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG7-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130346

DBCO-PEG4-DBCO	ADC Linker PROTAC Linkers	Cancer
DBCO-PEG4-DBCO is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-DBCO is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-141167

TCO-PEG4-NHS ester	ADC Linker PROTAC Linkers	Cancer
TCO-PEG4-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. TCO-PEG4-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-116186

m-PEG5-Ms	ADC Linker PROTAC Linkers	Cancer
m-PEG5-Ms is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG5-Ms is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W040214

m-PEG4-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG4-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG4-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W008429

m-PEG2-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG2-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG2-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-141379

N-Bromoacetyl-β-alanine	PROTAC Linkers ADC Linker	Cancer
N-Bromoacetyl-β-alanine is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. N-Bromoacetyl-β-alanine is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130571

m-PEG9-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG9-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG9-Amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-125541

DBCO-NHCO-PEG4-acid	ADC Linker PROTAC Linkers	Cancer
DBCO-Amide-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-Amide-PEG5-acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-117031

m-PEG8-Ms	ADC Linker PROTAC Linkers	Cancer
m-PEG8-Ms is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG8-Ms is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-145066

Gly-Gly-Gly-PEG4-azide
ADC Linker Cancer

Gly-Gly-Gly-PEG4-azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141355

OPSS-PEG36-acid
ADC Linker Cancer

OPSS-PEG36-acid is a cleavable 36 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-145489

Mal-PEG2-Val-Cit-PABA
ADC Linker Cancer

Mal-PEG2-Val-Cit-PABA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136106

Fmoc-Gly3-Val-Cit-PAB
ADC Linker Cancer

Fmoc-Gly3-Val-Cit-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-148550

MC-PEG2-NH2
ADC Linker Cancer

MC-PEG2-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141123

SPDP-C6-Gly-Leu-NHS ester
ADC Linker Cancer

SPDP-C6-Gly-Leu-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-144630

diSPhMC-Asn-Pro-Val-PABC-MMAE
ADC Linker Cancer

diSPhMC-Asn-Pro-Val-PABC-MMAE (compound 9) is a potent ADC Linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133408

4-Methyl-4-(methyldisulfanyl)pentanoic acid	ADC Linker	Cancer
4-Methyl-4-(methyldisulfanyl)pentanoic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-144629

Asn-Pro-Val-PABC-MMAE TFA
ADC Linker Cancer

Asn-Pro-Val-PABC-MMAE TFA (compound 8) is a potent ADC Linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126525

4-N3Pfp-NHS ester
ADC Linker Cancer

4-N3Pfp-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133585

Bis-SS-C3-sulfo-NHS ester
ADC Linker Cancer

Bis-SS-C3-sulfo-NHS ester is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-145367

Ala-CO-amide-C4-Boc
ADC Linker Cancer

Ala-CO-amide-C4-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141353

SPDP-PEG12-acid
ADC Linker Cancer

SPDP-PEG12-acid is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135971

BCN-PEG4-acid
ADC Linker Cancer

BCN-PEG4-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-78931

Boc-Dap-NE
ADC Linker Cancer

Boc-Dap-NE, a dipeptide, is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-44246

MC-Gly-Gly-Phe-Gly
ADC Linker Cancer

MC-Gly-Gly-Phe-Gly is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
HY-19318A

Fmoc-Val-D-Cit-PAB
ADC Linker Cancer

Fmoc-D-Val-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC).
HY-126496

PEG4-SPDP
ADC Linker Cancer

PEG4-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs).
HY-19318B

Fmoc-D-Val-Cit-PAB
ADC Linker Cancer

Fmoc-D-Val-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC).
HY-141593

Modified MMAF-C5-COOH
Drug-Linker Conjugates for ADC Cancer

Modified MMAF-C5-COOH is a agent-linker conjugate for ADC.

HY-128960

DBA-DM4	Drug-Linker Conjugates for ADC	Cancer
DBA-DM4 is a *agent-linker* conjugate** composed of a potent a tubulin inhibitor DM1 and a linker SPDP to make antibody agent conjugate (ADC).

HY-126682

Mal-VC-PAB-DM1	Drug-Linker Conjugates for ADC	Cancer
Mal-VC-PAB-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker Mal-VC-PAB .

HY-126693

SC-VC-PAB-DM1	Drug-Linker Conjugates for ADC	Cancer
SC-VC-PAB-DM1 is a agent-linker conjugate for ADC with with potent antitumor activity by using DM1 (Mertansine, a tubulin inhibitor) , linked via the ADC linker SC-VC-PAB.

HY-128904

MC-Val-Cit-PAB-duocarmycin chloride	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-duocarmycin chloride is a agent-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker MC-Val-Cit-PAB.

HY-128894

MC-Sq-Cit-PAB-Dolastatin10	Drug-Linker Conjugates for ADC	Cancer
MC-Sq-Cit-PAB-Dolastatin10 is a agent-linker conjugate for ADC with potent antitumor activity by using Dolastatin10 (a tubulin polymerization inhibitor), linked via the ADC linker MC-Sq-Cit-PAB.

HY-116427

Propargyl-PEG4-thiol	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130372

Propargyl-PEG9-bromide	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG9-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG9-bromide is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130591

Propargyl-PEG4-Br	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG4-Br is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-Br is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130377

Propargyl-PEG8-bromide	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG8-bromide is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-bromide is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-19812

*Acetylene-linker-Val-Cit-PABC-MMAE* LCB14-0602	Drug-Linker Conjugates for ADC	Cancer
Acetylene-linker-Val-Cit-PABC-MMAE (LCB14-0602) consists the ADCs linker (Acetylene-linker-Val-Cit-PABC) and potent tubulin inhibitor (MMAE). Acetylene-linker-Val-Cit-PABC-MMAE (LCB14-0602) is a agent-linker conjugate for ADC.

HY-136051

Biotin-PEG3-aldehyde
ADC Linker Cancer

Biotin-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136099

Bocaminooxyacetamide-PEG2-Azido
ADC Linker Cancer

Bocaminooxyacetamide-PEG2-Azido is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136044

APN-PEG4-BCN
ADC Linker Cancer

APN-PEG4-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-131156

Mal-PEG2-Val-Cit-PABA-PNP
ADC Linker Cancer

Mal-PEG2-Val-Cit-PABA-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136309

Ald-PEG23-SPDP
ADC Linker Cancer

Ald-PEG23-SPDP is a cleavable 23 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140115

Bis-(PEG6-acid)-SS
ADC Linker Cancer

Bis-(PEG6-acid)-SS is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136052

Tetrazine-PEG4-oxyamine hydrochloride	ADC Linker	Cancer
Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-138484

Folate-PEG3-amine
ADC Linker Cancer

Folate-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135961

PTAD-PEG4-amine
ADC Linker Cancer

PTAD-PEG4-amine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136086

Tetrazine-PEG6-amine hydrochloride	ADC Linker	Cancer
Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-148211

Tetrazine-PEG7-amine hydrochloride
ADC Linker Cancer

Tetrazine-PEG7-amine hydrochloride is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136049

APN-PEG4-DBCO
ADC Linker Cancer

APN-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-116655

Hydroxy-PEG1-acid
ADC Linker Cancer

Hydroxy-PEG1-acid is a non-cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W096133

Biotin-PEG1-azide
ADC Linker Cancer

Biotin-PEG1-azide is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135974

Amino-PEG3-SS-acid
ADC Linker Cancer

Amino-PEG3-SS-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140244

Gly-PEG3-amine
ADC Linker Cancer

Gly-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136046

PTAD-PEG4-alkyne
ADC Linker Cancer

PTAD-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140144

Mal-PEG1-Val-Cit-PAB-PNP
ADC Linker Cancer

Mal-PEG1-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140097

Amino-SS-PEG12-acid
ADC Linker Cancer

Amino-SS-PEG12-acid is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136045

APN-PEG4-tetrazine
ADC Linker Cancer

APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136067

DBCO-PEG4-HyNic
ADC Linker Cancer

DBCO-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136048

Methylcyclopropene-PEG4-NHS
ADC Linker Cancer

Methylcyclopropene-PEG4-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136127

ALD-PEG4-OPFP
ADC Linker Cancer

ALD-PEG4-OPFP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138488

Biotin-PEG4-PFP ester
ADC Linker Cancer

Biotin-PEG4-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136077

TCO-PEG3-aldehyde
ADC Linker Cancer

TCO-PEG3-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136061

BCN-PEG4-HyNic
ADC Linker Cancer

BCN-PEG4-HyNic is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135964

(2-pyridyldithio)-PEG4 acid
ADC Linker Cancer

(2-pyridyldithio)-PEG4 acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136050

TCO-PEG3-Biotin
ADC Linker Cancer

TCO-PEG3-Biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136075

HyNic-PEG4-alkyne
ADC Linker Cancer

HyNic-PEG4-alkyne is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136047

Methylcyclopropene-PEG3-amine
ADC Linker Cancer

Methylcyclopropene-PEG3-amine is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136101

Bocaminooxyacetamide-PEG3-alkyne
ADC Linker Cancer

Bocaminooxyacetamide-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136074

Methyltetrazine-PEG4-aldehyde
ADC Linker Cancer

Methyltetrazine-PEG4-aldehyde is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141358

SPDP-PEG36-NHS ester
ADC Linker Cancer

SPDP-PEG36-NHS ester is a cleavable 36 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130939

APN-PEG4-Amine hydrochloride
ADC Linker Cancer

APN-PEG4-Amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-132163

MP-PEG4-VK(Boc)G-OSu
ADC Linker Cancer

MP-PEG4-VK(Boc)G-OSu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136053

Tetrazine-PEG4-biotin
ADC Linker Cancer

Tetrazine-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130977

Tetrazine-PEG4-amine hydrochloride	ADC Linker	Cancer
Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140352

Azide-PEG5-Tos
ADC Linker Cancer

Azide-PEG5-Tos is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136038

Azido-PEG3-SSPy
ADC Linker Cancer

Azido-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-132086

(2-Pyridyldithio)-PEG6 acid
ADC Linker Cancer

2-Pyridyldithio-PEG6 acid is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136056

Methyltetrazine-PEG4-oxyamine
ADC Linker Cancer

Methyltetrazine-PEG4-oxyamine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136286

MC-DM1	Drug-Linker Conjugates for ADC	Cancer
MC-DM1 is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody agent conjugate (ADC).

HY-145989A

Aminobenzenesulfonic auristatin E TFA	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
Aminobenzenesulfonic auristatin E TFA is a agent-linker conjugate for ADC. Aminobenzenesulfonic auristatin E TFA has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic.

HY-42972

DBCO-acid	ADC Linker	Cancer
DBCO-acid is a cleavable ADC linker used in the synthesis of ADC linker DBCO-NHS ester (HY-115524 and HY-115545), and agent-linker conjugates DBCO-PEG-MMAE (HY-111012 and HY-126690).

HY-128929

Fmoc-PEA
ADC Linker Cancer

Fmoc-PEA (Example 1-2) is a used as a cleavable linker for antibody-drug conjugates (ADC).
HY-19318C

Fmoc-D-Val-D-Cit-PAB
ADC Linker Cancer

Fmoc-D-Val-D-Cit-PAB is a cleavable linker for antibody-agent-conjugation (ADC).
HY-79129

Fmoc-D-Trp(Boc)-OH
ADC Linker Cancer

Fmoc-D-Trp(Boc)-OH is a cleavable ADC linker that used in the synthesis of antibody-drug conjugates (ADCs).

HY-126974

Propargyl-PEG3-NHS ester	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG3-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG3-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130388

Propargyl-PEG5-NHS ester	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG5-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-117009

Bis-PEG9-NHS ester	ADC Linker PROTAC Linkers	Cancer
Bis-PEG9-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG9-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126889

Bis-PEG5-NHS ester	ADC Linker PROTAC Linkers	Cancer
Bis-PEG5-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG5-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130825

Bis-PEG13-NHS ester	PROTAC Linkers ADC Linker	Cancer
Bis-PEG13-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG13-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130381

Propargyl-PEG7-NHS ester	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG7-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130827

Bis-PEG21-NHS ester	PROTAC Linkers ADC Linker	Cancer
Bis-PEG21-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG21-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130385

Propargyl-PEG6-NHS ester	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG6-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130826

Bis-PEG17-NHS ester	ADC Linker PROTAC Linkers	Cancer
Bis-PEG17-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG17-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130828

Bis-PEG25-NHS ester	PROTAC Linkers ADC Linker	Cancer
Bis-PEG25-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG25-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130376

Propargyl-PEG8-NHS ester	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG8-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126890

Bis-PEG7-NHS ester	ADC Linker PROTAC Linkers	Cancer
Bis-PEG7-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG7-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130824

Bis-PEG10-NHS ester	PROTAC Linkers ADC Linker	Cancer
Bis-PEG10-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG10-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130925

BCN-PEG4-OH
ADC Linker Cancer

BCN-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140078

bis-PEG2-endo-BCN
ADC Linker Cancer

bis-PEG2-endo-BCN is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133431

DBCO-PEG3-SS-NHS ester
ADC Linker Cancer

DBCO-PEG3-SS-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135962

Boc-Aminooxy-PEG2-bromide
ADC Linker Cancer

Boc-Aminooxy-PEG2-bromide is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140124

THP-SS-PEG1-Tos
ADC Linker Cancer

THP-SS-PEG1-Tos is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130924

BCN-PEG3-Biotin
ADC Linker Cancer

BCN-PEG3-Biotin is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135966

Azido-PEG3-SS-NHS
ADC Linker Cancer

Azido-PEG3-SS-NHS is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130926

BCN-PEG3-oxyamine
ADC Linker Cancer

BCN-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136041

Boc-amino-PEG3-SSPy
ADC Linker Cancer

Boc-amino-PEG3-SSPy is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140130

PC Biotin-PEG3-alkyne
ADC Linker Cancer

PC Biotin-PEG3-alkyne is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140123

THP-SS-PEG1-Boc
ADC Linker Cancer

THP-SS-PEG1-Boc is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130927

BCN-PEG4-Ts
ADC Linker Cancer

BCN-PEG4-Ts is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133466

Methyltetrazine-PEG4-SS-NHS ester
ADC Linker Cancer

Methyltetrazine-PEG4-SS-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140108

Propargyl-PEG1-SS-alcohol
ADC Linker Cancer

Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136035

Methyltetrazine-SS-PEG4-Biotin
ADC Linker Cancer

Methyltetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133434

Aminoxyacetamide-PEG3-azide
ADC Linker Cancer

Aminoxyacetamide-PEG3-azide is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133428

DBCO-PEG3-TCO
ADC Linker Cancer

DBCO-PEG3-TCO is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136096

DBCO-PEG3 acetic-EVCit-PAB
ADC Linker Cancer

DBCO-PEG3 acetic-EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133430

DBCO-PEG4-alkyne
ADC Linker Cancer

DBCO-PEG4-alkyne is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-112561

Bis-PEG1-PFP ester
ADC Linker Cancer Inflammation/Immunology

Bis-PEG1-PFP ester is a non-cleavable (1 unit PEG) ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130955

Amino-bis-PEG3-TCO
ADC Linker Cancer

Amino-bis-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140134

PC Biotin-PEG3-NHS ester
ADC Linker Cancer

PC Biotin-PEG3-NHS ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140152

BCN-PEG3-VC-PFP ester
ADC Linker Cancer

BCN-PEG3-VC-PFP ester is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136078

Tetrazine-diazo-PEG4-biotin
ADC Linker Cancer

Tetrazine-diazo-PEG4-biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133432

DBCO-PEG4-SS-TCO
ADC Linker Cancer

DBCO-PEG4-SS-TCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130945

Tetrazine-PEG5-SS-amine
ADC Linker Cancer

Tetrazine-PEG5-SS-amine is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130972

Amino-bis-PEG3-DBCO
ADC Linker Cancer

Amino-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136087

Mal-bis-PEG3-DBCO
ADC Linker Cancer

Mal-bis-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136079

Methyltetrazine-PEG4-hydrazone-DBCO	ADC Linker	Cancer
Methyltetrazine-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140139

PC Alkyne-PEG4-NHS ester
ADC Linker Cancer

PC Alkyne-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136040

Tetrazine-PEG4-SS-NHS
ADC Linker Cancer

Tetrazine-PEG4-SS-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136085

Amino-bis-PEG3-BCN
ADC Linker Cancer

Amino-bis-PEG3-BCN is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136097

Maleimide-PEG2-hydrazide TFA
ADC Linker Cancer

Maleimide-PEG2-hydrazide (TFA) is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140930

Diazo Biotin-PEG3-DBCO
ADC Linker Cancer

Diazo Biotin-PEG3-DBCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136036

Tetrazine-SS-PEG4-Biotin
ADC Linker Cancer

Tetrazine-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133427

Propargyl-PEG4-hydrazide
ADC Linker Cancer

Propargyl-PEG4-hydrazide is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133429

DBCO-PEG3-oxyamine
ADC Linker Cancer

DBCO-PEG3-oxyamine is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136037

Boc-amino-PEG3-SS-acid
ADC Linker Cancer

Boc-amino-PEG3-SS-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140944

Biotin-PEG3-SS-azide
ADC Linker Cancer

Biotin-PEG3-SS-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140132

PC Biotin-PEG3-azide
ADC Linker Cancer

PC Biotin-PEG3-azide is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130947

Tetrazine-PEG4-SS-Py
ADC Linker Cancer

Tetrazine-PEG4-SS-Py is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-138508

Biotin-PEG2-methyl ethanethioate
ADC Linker Cancer

Biotin-PEG2-methyl ethanethioate is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140136

PC DBCO-PEG3-biotin
ADC Linker Cancer

PC DBCO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135979

DBCO-SS-PEG4-Biotin
ADC Linker Cancer

DBCO-SS-PEG4-Biotin is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-142740

Rha-PEG3-SMCC	Drug-Linker Conjugates for ADC	Cancer
Rha-PEG3-SMCC (compound 13) is a?agent-linker?conjugate?for?ADC?with?potent?antitumor?activity?by?using?SMCC?(a protein crosslinker),?linked?via?the noncleavable?ADC?linker?Rha-PEG3.

HY-126683

Mal-C6-α-Amanitin	Drug-Linker Conjugates for ADC	Cancer
Mal-C6-α-Amanitin is a agent-linker conjugate for ADC with potent antitumor activity by using α-Amanitin (an RNA polymerase II inhibitor), linked via the ADC linker Mal-C6.

HY-148339

Fmoc-VAP-MMAE	Drug-Linker Conjugates for ADC	Others
Fmoc-VAP-MMAE is a agent-linker conjugates for ADC. Fmoc-VAP-MMAE consists of an ADC linker and a tubulin inhibitor MMAE (HY-15162), with a protective Fmoc group.

HY-141385

N-Succinimidyl 3-(Bromoacetamido)propionate 3-(2-Bromoacetamido)propanoic acid NHS ester	PROTAC Linkers ADC Linker	Cancer
N-Succinimidyl 3-(Bromoacetamido)propionate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. N-Succinimidyl 3-(Bromoacetamido)propionate is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-126524

N3-Ph-NHS ester
ADC Linker Cancer

N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-114430

Fmoc-Phe-Lys(Boc)-PAB-PNP
ADC Linker Others

Fmoc-Phe-Lys(Boc)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-112616

*NAMPT inhibitor-linker* 2**	NAMPT Drug-Linker Conjugates for ADC	Cancer
NAMPT inhibitor-linker 2 is a agent-linker conjugates for *ADC, composed of an NAMPT* inhibitor as a payload, and a linker. ADC-4 consists of an NAMPT inhibitor-linker 2 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526, with IC₅₀s of <7 pM and 40 pM, respectively.

HY-41189

Fmoc-Val-Cit-PAB-PNP	ADC Linker	Cancer
Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers.

HY-120702

N-Boc-PEG5-bromide	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG5-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG5-bromide is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W006445

N-Boc-PEG3-bromide	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG3-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG3-bromide is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-111456

DBCO-NHCO-PEG4-NHS ester	ADC Linker PROTAC Linkers	Cancer
DBCO-NHCO-PEG4-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NHS ester is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130505

N-Boc-PEG7-alcohol	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG7-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG7-alcohol is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W071584

N-Boc-PEG6-alcohol	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG6-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG6-alcohol is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-141382

Bromoacetamido-PEG4-acid	PROTAC Linkers ADC Linker	Cancer
Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Bromoacetamido-PEG4-acid is also a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W046471

N-Boc-PEG4-bromide	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG4-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG4-bromide is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130503

N-Boc-PEG2-bromide	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG2-bromide is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG2-bromide is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-W071583

N-Boc-PEG9-alcohol	ADC Linker PROTAC Linkers	Cancer
N-Boc-PEG9-alcohol is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-PEG9-alcohol is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130934

TCO-PEG1-Val-Cit-OH
ADC Linker Cancer

TCO-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140309

Gly-Gly-Gly-PEG4-DBCO
ADC Linker Cancer

Gly-Gly-Gly-PEG4-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141190

Gly-Gly-Gly-PEG3-TCO
ADC Linker Cancer

Gly-Gly-Gly-PEG3-TCO is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141292

Oleoyl-Gly-Lys-N-(m-PEG11)
ADC Linker Cancer

Oleoyl-Gly-Lys-N-(m-PEG11) is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136134

SS-bis-amino-PEG4-NHS ester
ADC Linker Cancer

SS-bis-amino-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136034

Azido-PEG1-Val-Cit-OH
ADC Linker Cancer

Azido-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W096135

Biotin-PEG1-NH2
ADC Linker Cancer

Biotin-PEG1-NH2 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136135

(2-pyridyldithio)-PEG1-hydrazine
ADC Linker Cancer

(2-pyridyldithio)-PEG1-hydrazine is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133544

Mal-CO-PEG5-NHS ester
ADC Linker Cancer

Mal-CO-PEG5-?NHS ester is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130940

PTAD-PEG4-N3
ADC Linker Cancer

PTAD-PEG4-N3 is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130922

BCN-PEG1-Val-Cit-OH
ADC Linker Cancer

BCN-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140127

Azide-C2-SS-C2-biotin
ADC Linker Cancer

Azide-C2-SS-C2-biotin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140099

Amino-ethyl-SS-PEG3-NHBoc
ADC Linker Cancer

Amino-ethyl-SS-PEG3-NHBoc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141284

Gly-Gly-Gly-PEG4-methyltetrazine
ADC Linker Cancer

Gly-Gly-Gly-PEG4-methyltetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133435

Aminooxy-amido-PEG4-propargyl
ADC Linker Cancer

Aminooxy-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133538

4-Succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene	ADC Linker	Cancer
4-Succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136141

DBCO-PEG3-propionic EVCit-PAB
ADC Linker Cancer

DBCO-PEG3-propionic EVCit-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133459

Mal-PEG1-Val-Cit-OH
ADC Linker Cancer

Mal-PEG1-Val-Cit-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130962

Ald-Ph-amido-PEG23-OPSS
ADC Linker Cancer

Ald-Ph-amido-PEG23-OPSS is a cleavable 23 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130954

Hynic-PEG3-N3
ADC Linker Cancer

Hynic-PEG3-N3 is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-141833

Bi-Mc-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Bi-Mc-VC-PAB-MMAE consists ADCs linker (Fmoc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE). Bi-Mc-VC-PAB-MMAE is a agent-linker conjugate for ADC.

HY-19811

Fmoc-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
Fmoc-Val-Cit-PAB-MMAE consists the ADCs linker (Fmoc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE). Fmoc-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC.

HY-W034918

Docosanedioic acid	ADC Linker PROTAC Linkers	Cancer
Docosanedioic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Docosanedioic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-129361

Fmoc-Ala-Ala-Asn-PABC-PNP
ADC Linker Cancer

Fmoc-Ala-Ala-Asn-PABC-PNP is a peptide cleavable ADC linker.
HY-130956

Boc-NMe-Val-Val-Dil-Dap-OH
ADC Linker Cancer

Boc-NMe-Val-Val-Dil-Dap-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126533

PDP-C1-Ph-Val-Cit
ADC Linker Cancer

PDP-C1-Ph-Val-Cit is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
HY-138745

Bis-sulfone-PEG3-Azide
ADC Linker Cancer

Bis-sulfone-PEG3-Azide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-132251

MCC
ADC Linker Cancer

MCC is non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as MCC-DM1.

HY-112615

*NAMPT inhibitor-linker* 1**	Drug-Linker Conjugates for ADC	Cancer
NAMPT inhibitor-linker 1 is a agent-linker conjugates for *ADC, composed of an NAMPT* inhibitor as a payload, and a linker. ADC-3 consists of an NAMPT inhibitor-linker 1 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526 cells, with IC₅₀s of <3 pM and 9 pM, respectively.

HY-130941

Fmoc-N-bis-PEG3-NH-Boc
ADC Linker Cancer

Fmoc-N-bis-PEG3-NH-Boc is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140145

Mal-PEG4-Val-Cit-PAB-PNP
ADC Linker Cancer

Mal-PEG4-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136137

Azide-PEG1-Val-Cit-PABC-OH
ADC Linker Cancer

Azide-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140148

Azido-PEG3-Val-Cit-PAB-OH
ADC Linker Cancer

Azido-PEG3-Val-Cit-PAB-OH is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133576

Cyclooctyne-O-amido-PEG4-PFP ester	ADC Linker	Cancer
Cyclooctyne-O-amido-PEG4-PFP ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133575

Cyclooctyne-O-amido-PEG3-PFP ester	ADC Linker	Cancer
Cyclooctyne-O-amido-PEG3-PFP ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-141150

Azido-PEG5-Ala-Ala-Asn-PAB
ADC Linker Cancer

Azido-PEG5-Ala-Ala-Asn-PAB is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133545

Mal-Ph-CONH-PEG4-NHS ester
ADC Linker Cancer

Mal-Ph-CONH-PEG4-?NHS ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136100

TCO-PEG1-Val-Cit-PABC-PNP
ADC Linker Cancer

TCO-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136108

Fmoc-Gly3-Val-Cit-PAB-PNP
ADC Linker Cancer

Fmoc-Gly3-Val-Cit-PAB-PNP is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141149

Fmoc-PEG4-Ala-Ala-Asn-PAB
ADC Linker Cancer

Fmoc-PEG4-Ala-Ala-Asn-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136157

Py-ds-dmBut-amido-PEG4-NHS ester
ADC Linker Cancer

Py-ds-dmBut-amido-PEG4-NHS ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133426

Ald-Ph-amido-PEG4-propargyl Ald-benzyl-amide-PEG4-propargyl	ADC Linker	Cancer
Ald-Ph-amido-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140113

Acid-PEG3-SS-PEG3-acid
ADC Linker Cancer

Acid-PEG3-SS-PEG3-acid is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130966

TCO-PEG1-Val-Cit-PABC-OH
ADC Linker Cancer

TCO-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136155

Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester	ADC Linker	Cancer
Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136098

DBCO-PEG4-acetic-Val-Cit-PAB
ADC Linker Cancer

DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136054

N3-PEG5-aldehyde
ADC Linker Cancer

N3-PEG5-aldehyde is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140143

Mal-PEG4-Val-Cit-PAB-OH
ADC Linker Cancer

Mal-PEG4-Val-Cit-PAB-OH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-20336

Mc-Val-Cit-PABC-PNP Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate	ADC Linker	Cancer
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker. Mc-Val-Cit-PABC-PNP can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-141154

Amino-PEG4-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-131082

(R)-8-Azido-2-(Fmoc-amino)octanoic acid	ADC Linker	Cancer
(R)-8-Azido-2-(Fmoc-amino)octanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-131087

Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc	ADC Linker	Cancer
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140112

Acid-PEG2-SS-PEG2-acid
ADC Linker Cancer

Acid-PEG2-SS-PEG2-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130944

Mal-PEG1-Val-Cit-PABC-OH
ADC Linker Cancer

Mal-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133436

Boc-aminooxy-amide-PEG4-propargyl	ADC Linker	Cancer
Boc-aminooxy-amide-PEG4-propargyl is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133573

Cyclooctyne-O-amido-PEG2-PFP ester	ADC Linker	Cancer
Cyclooctyne-O-amido-PEG2-PFP ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-132973

MC-Val-Cit-PAB-NH-C2-NH-Boc
ADC Linker Cancer

MC-Val-Cit-PAB-NH-C2-NH-Boc is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133579

Ald-Ph-amido-PEG3-NHS ester
ADC Linker Cancer

Ald-Ph-amido-PEG3-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136103

DBCO-PEG4-Propionic-Val-Cit-PAB
ADC Linker Cancer

DBCO-PEG4-Propionic-Val-Cit-PAB is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133409

4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid	ADC Linker	Cancer
4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136105

Azido-PEG1-Val-Cit-PABC-PNP
ADC Linker Cancer

Azido-PEG1-Val-Cit-PABC-PNP is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130923

BCN-PEG1-Val-Cit-PABC-OH
ADC Linker Cancer

BCN-PEG1-Val-Cit-PABC-OH is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130449

N-Boc-N-bis(PEG4-OH)	ADC Linker PROTAC Linkers	Cancer
N-Boc-N-bis(PEG4-OH) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG4-OH) is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126688

Mal-C2-Gly3-EDA-PNU-159682	Drug-Linker Conjugates for ADC	Cancer
Mal-C2-Gly3-EDA-PNU-159682, a agent-linker conjugate for *ADC, consists a cleavable ADC* linker Mal-C2-Gly3-EDA and a potent ADC cytotoxin PNU-159682.

HY-126884

DBCO-NHCO-PEG4-NH-Boc	ADC Linker PROTAC Linkers	Cancer
DBCO-NHCO-PEG4-NH-Boc is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-NH-Boc is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-111554

AcLys-PABC-VC-Aur0101	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
AcLys-PABC-VC-Aur0101 is a agent-linker conjugate for ADC (anti-CXCR4 ADC) with potent antitumor activity by using Aur0101 (an auristatin microtubule inhibitor), linked via the cleavable linker AcLys-PABC-VC.

HY-12362

Val-cit-PAB-OH
ADC Linker Cancer

Val-cit-PAB-OH is a cleavable ADC linker.

HY-141155

endo-BCN-PEG4-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
endo-BCN-PEG4-Val-Cit-PAB-MMAE is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-141151

Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB
ADC Linker Cancer

Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140147

Mal-amido-PEG2-Val-Cit-PAB-PNP
ADC Linker Cancer

Mal-amido-PEG2-Val-Cit-PAB-PNP is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-141146

Mal-amido-PEG8-val-gly-PAB-OH
ADC Linker Cancer

Mal-amido-PEG8-val-gly-PAB-OH is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133572

Ald-Ph-amido-PEG11-NH-Boc
ADC Linker Cancer

Ald-Ph-amido-PEG11-NH-Boc is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140146

Mal-amido-PEG2-Val-Cit-PAB-OH
ADC Linker Cancer

Mal-amido-PEG2-Val-Cit-PAB-OH is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-132159

MC-AAA-NHCH2OCH2COOH
ADC Linker Cancer

MC-AAA-NHCH2OCH2COOH (compound 20) is a cleavable ADC linker that is used for making antibody-drug conjugate (ADC).
HY-W096148

Biotin-C4-amide-C5-NH2
ADC Linker Cancer

Biotin-C4-amide-C5-NH2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-139956

Mal-amido-PEG9-Val-Ala-PAB-SG3200
ADC Linker Cancer

Mal-amido-PEG9-Val-Ala-PAB-SG3200 is a cleavable ADC linker conjugate used in the synthesis of antibody-drug conjugates (ADCs).
HY-140109

Propargyl-PEG1-SS-PEG1-acid
ADC Linker Cancer

Propargyl-PEG1-SS-PEG1-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136076

TCO-PEG3-CH2-aldehyde
ADC Linker Cancer

TCO-PEG3-CH2-aldehyde is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136131

NH2-PEG4-hydrazone-DBCO
ADC Linker Cancer

NH2-PEG4-hydrazone-DBCO is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W125504

AEEA-AEEA	ADC Linker PROTAC Linkers	Cancer
AEEA-AEEA is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). AEEA-AEEA is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-129351

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP
ADC Linker Cancer

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-129378

NO2-SPP-sulfo-Me
ADC Linker Cancer

NO2-SPP-sulfo-Me is a cleavable linker that is used for making antibody-drug conjugate (ADC).
HY-W011561

Boc-NH-C6-Br
ADC Linker Cancer

Boc-NH-C6-Br is a non-cleavable linker used for antibody-drug conjugates (ADC).

HY-126918

THP-PEG6-OH	PROTAC Linkers ADC Linker	Cancer
THP-PEG6-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. THP-PEG6-OH is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W008005

Amino-PEG4-alcohol	PROTAC Linkers ADC Linker	Cancer
Amino-PEG4-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG4-alcohol is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-114995

Tr-PEG2-OH	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Tr-PEG2-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Tr-PEG2-OH is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130379

Propargyl-PEG8-acid	ADC Linker PROTAC Linkers Bacterial	Cancer Infection
Propargyl-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-acid is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). The ADCs can be used in bacterial infections caused by Gram-negative bacteria.

HY-115384

Amino-PEG5-C2-acid	ADC Linker PROTAC Linkers	Cancer
Amino-PEG5-C2-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG5-C2-acid is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-144628

Fmoc-Asn-Pro-Val-PABC-PNP
ADC Linker Cancer

Fmoc-Asn-Pro-Val-PABC-PNP (compound 6) is a potent ADC Linker.

HY-126687

Mal-PEG4-VC-PAB-DMEA-PNU-159682	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for *ADC, consists the ADC* linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU-159682.

HY-136133

NHS-PEG2-SS-PEG2-NHS
ADC Linker Cancer

NHS-PEG2-SS-PEG2-NHS is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140121

m-PEG6-SS-PEG6-methyl
ADC Linker Cancer

m-PEG6-SS-PEG6-methyl is a cleavable 12 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136058

N3-PEG4-amido-Lys(Fmoc)-acid
ADC Linker Cancer

N3-PEG4-amido-Lys(Fmoc)-acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-135970

Alkyne-PEG4-SS-PEG4-alkyne
ADC Linker Cancer

Alkyne-PEG4-SS-PEG4-alkyne is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-153345

Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br	ADC Linker PROTAC Linkers	Inflammation/Immunology
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br is an **ADC linker** that can be used as a reaction reagent for the synthesis of anti-CD40 antibody agent conjugates (ADCs).

HY-130968

Amino-PEG4-bis-PEG3-propargyl
ADC Linker Cancer

Amino-PEG4-bis-PEG3-propargyl is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136088

Acid-PEG1-bis-PEG3-BCN
ADC Linker Cancer

Acid-PEG1-bis-PEG3-BCN is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133581

Mal-PEG3-C1-NHS ester
ADC Linker Cancer

Mal-PEG3-C1-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130973

Mal-PEG4-bis-PEG4-propargyl
ADC Linker Cancer

Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-148474

Mal-Val-Ala-PABA-cGAMP	ADC Linker	Cancer
Mal-Val-Ala-PABA-cGAMP is a ADC linker that can be connected to a STING agonist. Mal-Val-Ala-PABA-cGAMP can be used for the synthesis of antibody-drug conjugates (ADCs).

HY-130971

Mal-PEG4-bis-PEG3-DBCO
ADC Linker Cancer

Mal-PEG4-bis-PEG3-DBCO is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130943

Methyltetrazine-PEG4-SS-PEG4-methyltetrazine	ADC Linker	Cancer
Methyltetrazine-PEG4-SS-PEG4-methyltetrazine is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140111

Propargyl-PEG1-SS-PEG1-propargyl
ADC Linker Cancer

Propargyl-PEG1-SS-PEG1-propargyl is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130970

Amino-PEG4-bis-PEG3-methyltetrazine	ADC Linker	Cancer
Amino-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130953

Mal-PEG4-bis-PEG3-methyltetrazine
ADC Linker Cancer

Mal-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136089

Aminooxy-PEG2-bis-PEG3-BCN
ADC Linker Cancer

Aminooxy-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140110

Propargyl-PEG1-SS-PEG1-PFP ester
ADC Linker Cancer

Propargyl-PEG1-SS-PEG1-PFP ester is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140634

Ald-CH2-PEG5-azide
ADC Linker Cancer

Ald-CH2-PEG5-azide is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140133

PC-Biotin-PEG4-PEG3-azide
ADC Linker Cancer

PC-Biotin-PEG4-PEG3-azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136060

Mal-PEG2-bis-PEG3-BCN
ADC Linker Cancer

Mal-PEG2-bis-PEG3-BCN is a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136318

β-D-tetraacetylgalactopyranoside-PEG1-N3	ADC Linker	Cancer
β-D-tetraacetylgalactopyranoside-PEG1-N3 is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130182

Propargyl-PEG8-NH2	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG8-NH2 (compound 3b) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG8-NH2 is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-140151

BCN-PEG3-Val-Cit	PROTAC Linkers ADC Linker	Cancer
BCN-PEG3-Val-Cit is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. BCN-PEG3-Val-Cit is also a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W002887

N-Boc-cis-4-Hydroxy-D-proline	ADC Linker PROTAC Linkers	Cancer
N-Boc-cis-4-Hydroxy-D-proline is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-Hydroxy-D-proline is also a alkyl chain-based PROTAC linker that can be used in the Synthesis of ADCs or PROTACs.

HY-117079

N-Boc-N-bis(PEG2-OH)	ADC Linker PROTAC Linkers	Cancer
N-Boc-N-bis(PEG2-OH) is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. N-Boc-N-bis(PEG2-OH) is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-112560

Bis-PEG2-PFP ester	PROTAC Linkers ADC Linker	Cancer
Bis-PEG2-PFP ester is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bis-PEG2-PFP ester is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-147270

MC-VA-PAB-Exatecan	Drug-Linker Conjugates for ADC	Cancer
MC-VA-PAB-Exatecan is a agent-linker conjugate for ADC. MC-VA-PAB-Exatecan contains the **ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). MC-VA-PAB-Exatecan synthesized ADC** shows good antitumor activity.

HY-101909

Val-Cit-PAB-MMAF	Drug-Linker Conjugates for ADC	Cancer
Val-Cit-PAB-MMAF is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)

HY-76043

H-Hyp-OMe hydrochloride	ADC Linker PROTAC Linkers	Cancer
H-Hyp-OMe hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). H-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1]<

HY-W010975

Fmoc-Lys-OH hydrochloride	ADC Linker PROTAC Linkers	Cancer
Fmoc-Lys-OH hydrochloride is a cleavable ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys-OH hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-101070

SMCC-DM1 DM1-SMCC	Drug-Linker Conjugates for ADC	Cancer
SMCC-DM1 (DM1-SMCC) is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker SMCC to make antibody agent conjugate (ADC).

HY-W016429

H-cis-Hyp-OMe hydrochloride	ADC Linker PROTAC Linkers	Cancer
H-cis-Hyp-OMe hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). H-cis-Hyp-OMe hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PR

HY-44177

Val-Cit-PAB-MMAF sodium	Drug-Linker Conjugates for ADC	Cancer
Val-Cit-PAB-MMAF sodium is a agent-linker conjugate for ADC. Val-Cit-PAB-MMAF sodium contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin polymerization inhibitor MMAF (HY-15579)

HY-126523

N3-C5-NHS ester
ADC Linker Cancer

N3-C5-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126521

N3-C3-NHS ester
ADC Linker Cancer

N3-C3-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-138651

PAB-Val-Lys-Boc	ADC Linker	Inflammation/Immunology
PAB-Val-Lys-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) for stimulating an immune response.

HY-126522

N3-C4-NHS ester
ADC Linker Cancer

N3-C4-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126520

N3-C2-NHS ester
ADC Linker Cancer

N3-C2-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-139107

Biotin-PEG4-SS-azide
ADC Linker Cancer

Biotin-PEG4-SS-azide is a cleavable, biotin-labeled, ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140081

Boc-gly-PEG3-endo-BCN	PROTAC Linkers ADC Linker	Cancer
Boc-gly-PEG3-endo-BCN is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Boc-gly-PEG3-endo-BCN is also a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W040135

Fmoc-NH-PEG8-CH2CH2COOH
ADC Linker PROTAC Linkers Cancer

Fmoc-NH-PEG8-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-133574

Mal-amido-PEG3-C1-PFP ester
ADC Linker Cancer

Mal-amido-PEG3-C1-PFP ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130929

β-Estradiol-6-CMO-PEG3-biotin
ADC Linker Cancer

β-Estradiol-6-CMO-PEG3-biotin is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W040246

Fmoc-NH-PEG6-CH2CH2COOH
ADC Linker PROTAC Linkers Cancer

Fmoc-NH-PEG6-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130967

Ald-Ph-PEG4-bis-PEG4-propargyl
ADC Linker Cancer

Ald-Ph-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130974

Ald-Ph-PEG4-bis-PEG3-methyltetrazine	ADC Linker	Cancer
Ald-Ph-PEG4-bis-PEG3-methyltetrazine is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-141091

Biotin-PEG4-Dde-TAMRA-PEG3-Azide
ADC Linker Cancer

Biotin-PEG4-Dde-TAMRA-PEG3-Azide is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130931

Propargyl-NH-PEG3-C2-NHS ester
ADC Linker Cancer

Propargyl-NH-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133539

Propargyl-C8-amido-PEG2-NHS ester	ADC Linker	Cancer
Propargyl-C8-amido-PEG2-NHS ester is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133582

Mal-amido-PEG3-C1-NHS ester
ADC Linker Cancer

Mal-amido-PEG3-C1-?NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130546

Hydroxy-PEG3-SS-PEG3-alcohol
ADC Linker Cancer

Hydroxy-PEG3-SS-PEG3-alcohol is also a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W017755

(R)-Azetidine-2-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
(R)-Azetidine-2-carboxylic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). (R)-Azetidine-2-carboxylic acid is also a alkyl chain-based PROTAC linker?that can be

HY-65039

Boc-Hyp-OMe	ADC Linker PROTAC Linkers	Cancer
Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-147239

MC-VA-PABC-MMAE	Drug-Linker Conjugates for ADC	Cancer
MC-VA-PABC-MMAE is a agent-linker conjugate for ADC. MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE (HY-15162).

HY-I0781

Boc-Hyp-OH	ADC Linker PROTAC Linkers	Cancer
Boc-Hyp-OH is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OH is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2]

HY-W018154

H-Glu-OtBu	ADC Linker PROTAC Linkers	Cancer
H-Glu-OtBu is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). H-Glu-OtBu is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2

HY-126689

Mal-Phe-C4-VC-PAB-DMEA-PNU-159682	Drug-Linker Conjugates for ADC	Cancer
Mal-Phe-C4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for *ADC, consists the ADC* linker Mal-Phe-C4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU-159682.

HY-126691

DBCO-PEG4-VC-PAB-DMEA-PNU-159682	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for?ADC, consists the ADC linker DBCO-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU-159682.

HY-131086

Me-triacetyl-β-D-glucopyranuronate-Ph-ald-NO2	ADC Linker	Cancer Inflammation/Immunology
Me-triacetyl-β-D-glucopyranuronate-Ph-ald-NO2 is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-126883

Tr-PEG4-OH
PROTAC Linkers Cancer Inflammation/Immunology

Tr-PEG4-OH is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136432

Mc-Gly-Gly-Phe-Gly-PAB-OH
Mc-GGFG-PAB-OH
ADC Linker Cancer

Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
HY-129311

Tr-PEG6-OH
ADC Linker Cancer Inflammation/Immunology

Tr-PEG6-OH is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-120258

Tr-PEG3-OH
ADC Linker Cancer Inflammation/Immunology

Tr-PEG3-OH is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-115374

m-PEG6-azide
ADC Linker Cancer Inflammation/Immunology

m-PEG6-azide is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-W019793

m-PEG8-NHS ester
ADC Linker Cancer Inflammation/Immunology

m-PEG8-NHS ester is a non-cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-128905

MC-Val-Cit-PAB-dimethylDNA31	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-dimethylDNA31 is a agent-linker conjugate for ADC with potent antitumor activity by using dimethylDNA31, linked via the ADC linker MC-Val-Cit-PAB. DimethylDNA31 has effective bactericidal activity against persisters and stationary-phase S. aureus.

HY-44149

m-C-tri(CH2-PEG1-NHS ester)
ADC Linker Cancer

m-C-tri(CH2-PEG1-NHS ester) is a non-cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136090

Amino-PEG4-bis-PEG3-N3
ADC Linker Cancer

Amino-PEG4-bis-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-40144

Azetidin-3-ol hydrochloride	ADC Linker PROTAC Linkers	Cancer
Azetidin-3-ol hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Azetidin-3-ol hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthes PROTAC.

HY-141596

Lys-Nε-SPDB-DM4	Drug-Linker Conjugates for ADC	Cancer
Lys-Nε-SPDB-DM4 is a *agent-linker* conjugate** composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody agent conjugate (ADC).

HY-79125

Fmoc-Hyp(Bom)-OH	ADC Linker PROTAC Linkers	Cancer
Fmoc-Hyp(Bom)-OH is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Hyp(Bom)-OH is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs<

HY-147307

MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan	Drug-Linker Conjugates for ADC	Cancer
MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is a agent-linker conjugate for ADC, contains the **ADC linker (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic acid) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan synthesized ADC** can be used in study of cancer.

HY-114233

MC-GGFG-Exatecan MC-GGFG-DX8951	Drug-Linker Conjugates for ADC	Cancer
MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC).

HY-130572

Azido-PEG5-acid	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Azido-PEG5-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs, such as the conjugate CPT-APO (CPT: Camptothecin (HY-16560)). Azido-PEG5-acid is a non-cleavable 5 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W019798

NH2-PEG9-acid	ADC Linker PROTAC Linkers	Cancer
NH2-PEG9-acid is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG9-acid also is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W040132

Boc-NH-PEG4-CH2CH2COOH	PROTAC Linkers ADC Linker	Cancer
Boc-NH-PEG4-CH2CH2COOH is a PEG-based PROTAC linker can be used in the synthesis of PROTAC. Boc-NH-PEG4-CH2CH2COOH is also a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC).

HY-130107

Ald-Ph-NHS ester
ADC Linker Cancer

Ald-Ph-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC).
HY-129365

SNPB
ADC Linker Cancer

SNPB is a cleavable linker that is used for making antibody-drug conjugate (ADC).

HY-108379

Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid	ADC Linker	Cancer
Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-140101

Azido-C2-SS-PEG2-C2-acid
ADC Linker Cancer

Azido-C2-SS-PEG2-C2-acid is a cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-131085

Desmethyl Vc-seco-DUBA	Drug-Linker Conjugates for ADC	Cancer
Desmethyl Vc-seco-DUBA consists a cleavable ADC linker (Desmethyl Vc-seco) and a DNA alkylating agent (DUBA). Desmethyl Vc-seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-130957

Amino-PEG6-amido-bis-PEG5-N3
ADC Linker Cancer

Amino-PEG6-amido-bis-PEG5-N3 is a cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130969

Ald-Ph-PEG4-bis-PEG3-N3
ADC Linker Cancer

Ald-Ph-PEG4-bis-PEG3-N3 is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-126958

Biotin-PEG2-acid	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Biotin-PEG2-acid is a non-cleavable 2 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). Biotin-PEG2-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-136288

Azide-PEG4-VC-PAB-Doxorubicin	Drug-Linker Conjugates for ADC	Cancer
Azide-PEG4-VC-PAB-Doxorubicin is a agent-linker conjugate composed of a cytotoxic anthracycline antibiotic Doxorubicin and a linker Azide-PEG4-VC-PAB to make antibody agent conjugate (ADC).

HY-130475

Azido-PEG9-acid	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Azido-PEG9-acid is a non-cleavable 9 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-126960

Mal-PEG1-acid	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Mal-PEG1-acid is is a non-cleavable 1 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG1-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-136432A

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA
Mc-GGFG-PAB-OH TFA
ADC Linker Cancer

Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) TFA is a cleavable ADC linker used for antibody-drug conjugates (ADCs).

HY-145989S

Aminobenzenesulfonic auristatin E-d8	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
Aminobenzenesulfonic auristatin E-d₈ is the deuterium labeled Aminobenzenesulfonic auristatin E. Aminobenzenesulfonic auristatin E is a drug-linker conjugate for ADC. Aminobenzenesulfonic auristatin E has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic[1][2].

HY-130486

NH2-PEG6-Boc	PROTAC Linkers ADC Linker	Cancer
NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-129637

NH2-PEG5-OH	PROTAC Linkers ADC Linker	Cancer
NH2-PEG5-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG5-OH is also a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133546

Ald-Ph-amido-PEG11-C2-NH2
ADC Linker Cancer

Ald-Ph-amido-PEG11-C2-NH2 is a non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-140242

NH2-PEG4-Lys(Boc)-NH-(m-PEG24)
ADC Linker Cancer

NH2-PEG4-Lys(Boc)-NH-(m-PEG24) is a cleavable 28 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-136084

Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO)
ADC Linker Cancer

Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) is a cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-136130

N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol	ADC Linker	Cancer
N,N-Bis(PEG2-alkyne)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130328

NH-bis-PEG2	ADC Linker PROTAC Linkers	Cancer
NH-bis-PEG2 is a non-cleavable 2 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). NH-bis-PEG2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-33615

Methyl azetidine-3-carboxylate hydrochloride	ADC Linker PROTAC Linkers	Cancer
Methyl azetidine-3-carboxylate hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Methyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs<

HY-W040222

m-PEG11-Amine	ADC Linker PROTAC Linkers	Cancer
m-PEG11-Amino is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). m-PEG11-Amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-15750

Cys-mcMMAD
Microtubule/Tubulin Drug-Linker Conjugates for ADC Cancer

Cys-mcMMAD is a agent-linker conjugate for ADC. MMAD is a potent tubulin inhibitor.
HY-129376

Sulfo-SNPB
ADC Linker Cancer

Sulfo-SNPB is a cleavable linker that is used for making antibody-drug conjugate (ADC).
HY-19318

Fmoc-Val-Cit-PAB
ADC Linker Cancer

Fmoc-Val-Cit-PAB is a cleavable linker for antibody-drug-conjugation (ADC).
HY-126519

PDdEC-NB
ADC Linker Cancer

PDdEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate?(ADC).

HY-126668

Mal-PEG4-VC-PAB-DMEA	ADC Linker	Cancer
Mal-PEG4-VC-PAB-DMEA is a cleavable **ADC linker** containing a Maleimide group. Mal-PEG4-VC-PAB-DMEA is used in the synthesis of antibody-drug conjugates (ADCs).

HY-126672

Mal-PEG4-Val-Cit-PAB	ADC Linker	Cancer
Mal-PEG4-Val-Cit-PAB is a cleavable **ADC linker** containing a Maleimide group. Mal-PEG4-Val-Cit-PAB is used in the synthesis of antibody-drug conjugates (ADCs).

HY-Y0530

Azetidine-3-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
Azetidine-3-carboxylic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2

HY-130165

Tr-PEG8-OH	ADC Linker PROTAC Linkers	Cancer Inflammation/Immunology
Tr-PEG8-OH is a non-cleavable 8 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). Tr-PEG8-OH is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-120845

Tr-PEG5-OH	ADC Linker PROTAC Linkers	Cancer Inflammation/Immunology
Tr-PEG5-OH is a non-cleavable 5 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). Tr-PEG5-OH is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-W019213

cis-4-Hydroxy-L-proline hydrochloride	ADC Linker PROTAC Linkers	Cancer
cis-4-Hydroxy-L-proline hydrochloride is a cleavable ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-L-proline hydrochloride is also a PEG-based?PROTAC linker?that can be used in the synthesis of PROTACs.

HY-W017882

Boc-trans-D-Hyp-OMe	ADC Linker PROTAC Linkers	Cancer
Boc-trans-D-Hyp-OMe is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Boc-trans-D-Hyp-OMe is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-126494

DM4-SMCC	Drug-Linker Conjugates for ADC	Cancer
DM4-SMCC is a agent-linker conjugate for ADC with antitumor activity by using DM4 (an antitubulin agent), linked via the non-cleavable SMCC linker.

HY-120903

DBCO-C3-Acid
ADC Linker Cancer

DBCO-C3-Acid is a Click Chemistry intermediate used in the synthesis of antibody-drug conjugate (ADC) linker.

HY-130524

Amino-PEG4-CH2COOH	PROTAC Linkers ADC Linker	Cancer
Amino-PEG4-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Amino-PEG4-CH2COOH is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133583

Propargyl-O-C1-amido-PEG3-C2-NHS ester	ADC Linker	Cancer
Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W003511

tans-4-Hydroxy-D-proline hydrochloride	ADC Linker PROTAC Linkers	Cancer
tans-4-Hydroxy-D-proline hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PR

HY-W045598

Boc-C16-COOH	ADC Linker PROTAC Linkers	Cancer
Boc-C16-COOH is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Boc-C16-COOH is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs

HY-141156

Mal-PEG8-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG8-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAE contains a cleavable ADC linker and a potent tubulin inhibitor MMAE (HY-15162).

HY-147286

Ac-Lys-Val-Cit-PABC-MMAE	Drug-Linker Conjugates for ADC	Cancer
Ac-Lys-Val-Cit-PABC-MMAE is a agent-linker conjugate for ADC. Ac-Lys-Val-Cit-PABC-MMAE contains the **ADC linker (peptide Ac-Lys-Val-Cit-PABC) and a potent tubulin** polymerization inhibitor MMAE (HY-15162).

HY-W011277

Fmoc-azetidine-3-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
Fmoc-azetidine-3-carboxylic acid is a cleavable ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-77475

1-Cbz-3-Hydroxyazetidine	ADC Linker PROTAC Linkers	Cancer
1-Cbz-3-Hydroxyazetidine is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-3-Hydroxyazetidine is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-134723

DBCO-PEG4-GGFG-Exatecan DBCO-PEG4-GGFG-DX8951	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-GGFG-Exatecan (DBCO-PEG4-GGFG-DX8951) is a agent-linker conjugate for ADC with potent antitumor activity by using DX8951 (a DNA topoisomerase I inhibitor), linked via the cleavable ADC linker DBCO-PEG4-GGFG.

HY-42640

Boc-NH-PEG4-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Boc-NH-PEG4-CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-111555

AmPEG6C2-Aur0131	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
AmPEG6C2-Aur0131 is a agent-linker conjugate for ADC (anti-CXCR4 ADC) with potent antitumor activity by using Aur0131 (an auristatin microtubule inhibitor), linked via the non-cleavable linker AmPEG6C2.

HY-128910

MC-VC(S)-PABQ-Tubulysin M	Drug-Linker Conjugates for ADC	Cancer
MC-VC(S)-PABQ-Tubulysin M is a agent-linker conjugate for ADC with potent antitumor activity by using Tubulysin M (a tubulin inhibitor), linked via the ADC linker MC-VC(S)-PABQ. MC-VC(S)-PABQ-Tubulysin M is effective against multidrug-resistant lymphoma cell lines and tumors.

HY-129375

SNPB-sulfo-Me
ADC Linker Cancer

SNPB-sulfo-Me is a cleavable linker that is used for making antibody-drug conjugate (ADC).
HY-44235

MC-Gly-Gly-Phe
ADC Linker Cancer

MC-Gly-Gly-Phe is a cleavable linker used for antibody-drug conjugates (ADC).
HY-130096

Ald-Ph-amido-C2-nitrate
ADC Linker Cancer

Ald-Ph-amido-C2-nitrate (Example XXIVb) is a thiazolidine derivative, used as a noncleavable ADC linker.
HY-130091

NHPI-PEG4-C2-NHS ester
ADC Linker Cancer

NHPI-PEG4-C2-NHS ester, example 40 (WO2014185985A1), is used as a linker for antibody-drug conjugates (ADC).

HY-136129

N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol	ADC Linker	Cancer
N,N-Bis(PEG2-N3)-N-amido-PEG2-thiol is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-76105

D-Proline, 4-hydroxy-, methyl ester hydrochloride	ADC Linker PROTAC Linkers	Cancer
D-Proline, 4-hydroxy-, methyl ester hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). D-Proline, 4-hydroxy-, methyl ester hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2

HY-W052600

Ethyl azetidine-3-carboxylate hydrochloride	ADC Linker PROTAC Linkers	Cancer
Ethyl azetidine-3-carboxylate hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Ethyl azetidine-3-carboxylate hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2]

HY-W034599

Boc-C14-COOH	ADC Linker PROTAC Linkers	Cancer
Boc-C14-COOH is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Boc-C14-COOH is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-W019799

Amino-PEG8-Boc	ADC Linker PROTAC Linkers	Cancer
Amino-PEG8-Boc is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG8-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-145929

MC-Val-Cit-PAB-Exatecan MC-Val-Cit-PAB-DX8951	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker.

HY-W045822

Fmoc-Lys(Pal-Glu-OtBu)-OH	ADC Linker PROTAC Linkers	Cancer
Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Lys(Pal-Glu-OtBu)-OH is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-W046348

22-(tert-Butoxy)-22-oxodocosanoic acid	ADC Linker PROTAC Linkers	Cancer
22-(tert-Butoxy)-22-oxodocosanoic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 22-(tert-Butoxy)-22-oxodocosanoic acid is also a alkyl chain-based PROTAC linker?that can be used in t

HY-133066

m-PEG6-NHS ester	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
m-PEG6-NHS ester is a non-cleavable 6 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-NHS ester is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.

HY-139859

APN-PEG36-tetrazine	ADC Linker	Cancer
APN-PEG36-tetrazine is an analogue of APN-PEG4-tetrazine. APN-PEG4-tetrazine is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-100216

SPDP SPDP CrossLinker	ADC Linker	Cancer
SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. It is a glutathione cleavable **ADC linker** used for the antibody-drug conjugates (ADCs).

HY-126942

Amino-PEG6-alcohol	ADC Linker PROTAC Linkers	Cancer
Amino-PEG6-alcohol is a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG6-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130324

Azido-PEG7-amine	ADC Linker PROTAC Linkers	Cancer
Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG7-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-100374

Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Val-Cit-PAB-MMAE is a?agent-linker conjugate for ADC. Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE (HY-15162). MMAE?a potent?mitotic?inhibitor by inhibiting tubulin polymerization.

HY-130298

Amino-PEG11-OH	ADC Linker PROTAC Linkers	Cancer
Amino-PEG11-OH is non-cleavable 11 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG11-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W034597

20-(tert-Butoxy)-20-oxoicosanoic acid	ADC Linker PROTAC Linkers	Cancer
20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 20-(tert-Butoxy)-20-oxoicosanoic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs

HY-130169

Azido-PEG9-amine	ADC Linker PROTAC Linkers	Cancer
Azido-PEG9-amine is a non-cleavable 9 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG9-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-40142

1-N-Boc-3-hydroxyazetidine	ADC Linker PROTAC Linkers	Cancer
1-N-Boc-3-hydroxyazetidine is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 1-N-Boc-3-hydroxyazetidine is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs

HY-120761

Amino-PEG10-OH	ADC Linker PROTAC Linkers	Cancer
Amino-PEG10-OH is non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG10-OH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-47018

BCN-HS-PEG2-VA-PABC-SG3199
ADC Linker Others

BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine that can be used as a agent linker of antibody-drug conjugates (ADC).
HY-23642

Mal-amido-(CH2COOH)2
ADC Linker Cancer

Mal-amido-(CH2COOH)2, compound 7a, is a maleimidoethyl-containing intermediate for hydrophilic ADC linker.

HY-130690

Propargyl-PEG1-SS-PEG1-C2-Boc	ADC Linker PROTAC Linkers	Cancer
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-126498

PDEC-NB
ADC Linker Cancer

PDEC-NB is a disulfide cleavable linker used for the antibody-drug conjugate?(ADC).
HY-126511

Propargyl-C1-NHS ester
ADC Linker Cancer

Propargyl-C1-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC).
HY-126512

Propargyl-C2-NHS ester
ADC Linker Cancer

Propargyl-C2-NHS ester is a nonclaevable linker for antibody-agent-conjugation (ADC).
HY-129371

SPDV
ADC Linker Cancer

SPDV is a cleavable ADC linker used for diagnosis and treatment of cancer or B cell proliferative diseas.
HY-128927

Mc-Leu-Gly-Arg
ADC Linker Cancer

Mc-Leu-Gly-Arg is a cleavable ether linker for antibody-drug conjugates (ADC) design.
HY-129374

SPDH
ADC Linker Cancer

SPDH is a cleavable ADC linker used for diagnosis and treatment of cancer or B cell proliferative diseas.

HY-131057

Mc-VC-PAB-SN38	Drug-Linker Conjugates for ADC	Cancer
Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-130989

SuO-Glu-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
SuO-Glu-Val-Cit-PAB-MMAE consists a cleavable ADC linker (SuO-Glu-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). SuO-Glu-Val-Cit-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-76104

cis-4-Hydroxy-D-proline hydrochloride	ADC Linker PROTAC Linkers	Cancer
cis-4-Hydroxy-D-proline hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). cis-4-Hydroxy-D-proline hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-W042654

BnO-PEG6-OH	ADC Linker PROTAC Linkers	Cancer Inflammation/Immunology
BnO-PEG6-OH is a non-cleavable 6 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). BnO-PEG6-OH is also a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

HY-126676

DBCO-(PEG2-Val-Cit-PAB)2	ADC Linker PROTAC Linkers	Cancer
DBCO-(PEG2-Val-Cit-PAB)2 is a dual cleavable **ADC linker** for antibody-drug conjugates (ADCs). DBCO-(PEG2-Val-Cit-PAB)2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130150

m-PEG5-succinimidyl carbonate	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
m-PEG5-succinimidyl carbonate is a non-cleavable 5 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-succinimidyl carbonate is a PEG/Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs.

HY-148820

Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a *agent-linker* conjugate** that composed of a potent topoisomerase I inhibitor and a linker to make antibody agent conjugate (ADC).

HY-101162

SGD-1910	Drug-Linker Conjugates for ADC	Cancer
SGD-1910 is a agent-linker conjugate for ADC by using the antitumor antibiotic, pyrrolobenzodiazepine (PBD, a cytotoxic DNA crosslinking), linked via the cleavable linker MC-Val-Ala.

HY-130100

Ald-Ph-amido-PEG3-C1-Boc
ADC Linker Cancer

Ald-Ph-amido-PEG3-C1-Boc is an ADC linker, which belongs to a polyethylene glycol (PEG) linker.

HY-101141

sulfo-SPDB-DM4	Drug-Linker Conjugates for ADC	Cancer
sulfo-SPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, an antitubulin agent) via the sulfo-SPDB linker.

HY-152916

mp-dLAE-PABC-MMAE	Drug-Linker Conjugates for ADC	Cancer
mp-dLAE-PABC-MMAE is a agent-linker conjugate for ADC. mp-dLAE-PABC-MMAE contains a potent tubulin inhibitor Monomethyl auristatin E (HY-15162). mp-dLAE-PABC-MMAE can be used to synthesis antibody-drug conjugates (ADCs).

HY-W004868

1-Cbz-azetidine-3-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
1-Cbz-azetidine-3-carboxylic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1]

HY-42149

NH2-PEG2-C2-Boc	PROTAC Linkers ADC Linker	Cancer
NH2-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG2-C2-Boc is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-129353

Boc-Phe-(Alloc)Lys-PAB-PNP
ADC Linker Cancer

Boc-Phe-(Alloc)Lys-PAB-PNP is a used as a cleavable linker for antibody-drug conjugates (ADC).
HY-129367

NO2-SPP
ADC Linker Cancer

NO2-SPP is a cleavable linker that is used for making antibody-drug conjugate (ADC).
HY-129352

Cbz-Phe-(Alloc)Lys-PAB-PNP
ADC Linker Cancer

Cbz-Phe-(Alloc)Lys-PAB-PNP is an cleavable linker for antibody-drug conjugates (ADC) design.

HY-120775

Boc-NH-PEG1-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Boc-NH-PEG1-CH2CH2COOH is a cleavable (1 unit PEG) ADC linker and also a PEG- and Alkyl/ether-based PROTAC linker can be used in the synthesis of antibody-drug conjugates (ADCs) or PROTACs.

HY-W040165

Amino-PEG3-C2-acid	ADC Linker PROTAC Linkers	Cancer
Amino-PEG3-C2-acid is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG3-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W006629

tans-4-Hydroxy-D-proline methyl ester hydrochloride	ADC Linker PROTAC Linkers	Cancer
tans-4-Hydroxy-D-proline methyl ester hydrochloride is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). tans-4-Hydroxy-D-proline methyl ester hydrochloride is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-40141

1-Boc-azetidine-3-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
1-Boc-azetidine-3-carboxylic acid is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2]

HY-148057

TCO-PEG4-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
TCO-PEG4-VC-PAB-MMAE is a agent-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE (HY-15162).

HY-W002886

N-Boc-cis-4-hydroxy-L-proline	ADC Linker PROTAC Linkers	Cancer
N-Boc-cis-4-hydroxy-L-proline is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2

HY-139018

TLR7/8 agonist 4 hydroxy-PEG10-acid	Drug-Linker Conjugates for ADC	Cancer
TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a agent-linker conjugate for ADC with potent antitumor activity by using TLR7/8 agonist 4 (HY-139018; a TLR7/8 agonist), linked via the cleavable ADC linker hydroxy-PEG10-acid (HY-133307).

HY-139018A

TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride	Drug-Linker Conjugates for ADC	Cancer
TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) is a agent-linker conjugate for ADC with potent antitumor activity by using TLR7/8 agonist 4 (HY-139018; a TLR7/8 agonist), linked via the cleavable ADC linker hydroxy-PEG10-acid (HY-133307).

HY-130102

Ald-Ph-amido-PEG3-C2-Pfp ester
ADC Linker Cancer

Ald-Ph-amido-PEG3-C2-Pfp ester is an noncleavable ADC linker, which belongs to a polyethylene glycol (PEG) linker.

HY-126532

Fmoc-Val-Cit-PAB-Duocarmycin TM	Drug-Linker Conjugates for ADC	Cancer
Fmoc-Val-Cit-PAB-Duocarmycin TM is a agent-linker conjugate for ADC by using the antitumor antibiotic, Duocarmycin TM, linked via Fmoc-Val-Cit-PAB.

HY-133492

DBCO-PEG4-MMAF	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the tubulin polymerization inhibitor, MMAF, linked via the cleavable linker DBCO-PEG4.

HY-131056

Gly3-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Gly3-VC-PAB-MMAE consists a cleavable ADC linker (Gly3-VC-PAB) and a potent tubulin inhibitor (MMAE). Gly3-VC-PAB-MMAE can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-130485

Bromo-PEG2-C2-azide	ADC Linker PROTAC Linkers	Cancer
Bromo-PEG2-C2-azide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Bromo-PEG2-C2-azide is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W040168

Amino-PEG2-C2-acid	ADC Linker PROTAC Linkers	Cancer
Amino-PEG2-C2-acid is a cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG2-C2-acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-40151

Methyl 1-Boc-azetidine-3-carboxylate	ADC Linker PROTAC Linkers	Cancer
Methyl 1-Boc-azetidine-3-carboxylate is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Boc-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1

HY-40152

1-Boc-azetidine-3-yl-methanol	ADC Linker PROTAC Linkers	Cancer
1-Boc-azetidine-3-yl-methanol is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). 1-Boc-azetidine-3-yl-methanol is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1]

HY-120537

m-PEG5-CH2COOH	ADC Linker PROTAC Linkers	Cancer
m-PEG5-CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W019226

Methyl 1-Cbz-azetidine-3-carboxylate	ADC Linker PROTAC Linkers	Cancer
Methyl 1-Cbz-azetidine-3-carboxylate is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). Methyl 1-Cbz-azetidine-3-carboxylate is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1

HY-Y0755

N-Boc-4-hydroxy-L-proline methyl ester	ADC Linker PROTAC Linkers	Cancer
N-Boc-cis-4-hydroxy-L-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-L-proline methyl ester is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[2

HY-121805

DBCO-C6-acid	ADC Linker	Cancer
DBCO-C6-acid is a non-cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). DBCO-C6-acid can be used in the synthesis of carmaphycin analogues.

HY-130099

Ald-Ph-amido-PEG2
ADC Linker Cancer

Ald-Ph-amido-PEG2 is a noncleavable ADC linker for antibody-drug conjugate.

HY-128954

Sulfo-PDBA-DM4	Drug-Linker Conjugates for ADC	Cancer Inflammation/Immunology
Sulfo-PDBA-DM4 is a *agent-linker* conjugate** composed of a potent a tubulin inhibitor DM4 and a linker Sulfo-PDBA to make antibody agent conjugate (ADC). Sulfo-PDBA is a gluthatione cleavable linker.

HY-135660

MMAE-SMCC	Drug-Linker Conjugates for ADC	Cancer
MMAE-SMCC is a agent-linker conjugate for ADC. MMAE-SMCC is composed of a potent?mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody agent conjugate.

HY-130946

NH2-C5-PEG4-N3-L-Lysine-PEG3-N3
ADC Linker Cancer

NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 is a cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-130435

DBCO-PEG4-amine	ADC Linker PROTAC Linkers	Cancer
DBCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-PEG4-amine is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). DBCO-PEG4-amine can be used in the synthesis of FPM-PEG4-DBCO (a homobifunctional azide-to-azide cross-linker).

HY-W040244

Boc-NH-PEG6-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Boc-NH-PEG6-CH2CH2COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates (ADC). Boc-NH-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-132180A

Seco-DUBA	ADC Cytotoxin	Cancer Inflammation/Immunology
Seco-DUBA is a duocarmycin (DUBA) prodrug containing two hydroxyl groups, which can each be used for coupling to an antibody via a linker. Seco-DUBA can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-130653

Azido-PEG4-C2-acid	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
Azido-PEG4-C2-acid a PEG-based PROTAC linker can be used in the synthesis of vRucaparib-TP4. Azido-PEG4-C2-acid is also a non-cleavable 4 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-133062

Fmoc-NH-PEG5-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG5-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG5-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130364

Fmoc-NH-PEG6-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG6-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W002680

N-Boc-cis-4-hydroxy-D-proline methyl ester	ADC Linker PROTAC Linkers	Cancer
N-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs^[1

HY-133063

Fmoc-NH-PEG8-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG8-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG8-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W055861

Fmoc-NH-PEG1-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG1-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG1-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130175

Fmoc-NH-PEG4-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG4-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-77593

(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid	ADC Linker PROTAC Linkers	Cancer
N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is a non-cleavable?ADC linker?used in the synthesis of antibody-drug conjugates (ADCs). N-tert-Butoxycarbonyl-trans-4-hydroxy-D-proline is also a alkyl chain-based PROTAC linker?that can be used in the synthesis of PROTACs.

HY-12460

SPDB-DM4	Drug-Linker Conjugates for ADC	Cancer
SPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, a tubulin inhibitor) via a SPDB linker, exhibiting potent anti-tumor activity.

HY-128962

AZ1508 MC-Lys-MMETA	Drug-Linker Conjugates for ADC	Cancer
AZ1508 is a agent-linker conjugates for ADC for the treatment of breast and stomach cancer, and the agent is a tubulin inhibitor.

HY-78738

MC-Val-Cit-PAB
ADC Linker Cancer

MC-Val-Cit-PAB is a cathepsin cleavable ADC linker that is used for making antibody-drug conjugate.
HY-141664

PPA
ADC Linker Cancer

PPA is an ADC linker (US20060073528A1). PPA can be used for making antibody-drug conjugate.

HY-114325

AcLysValCit-PABC-DMAE-SW-163D	Drug-Linker Conjugates for ADC	Cancer
AcLysValCit-PABC-DMAE-SW-163D is a agent-linker conjugates for ADC which consists of a natural bis-intercalator, SW-163D, conjugated via an AcLysValCitPABC-DMAE linker.

HY-13631E

Deruxtecan	Drug-Linker Conjugates for ADC	Cancer
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

HY-126685

Mal-PEG4-VA-PBD	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG4-VA-PBD is a agent-linker conjugate for *ADC* by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via Mal-PEG4-VA.

HY-126681

SC-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
SC-VC-PAB-MMAE is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker SC-VC-PAB.

HY-130089

Bis-PEG1-NHS ester
ADC Linker Cancer

Bis-PEG1-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130090

NHPI-PEG4-C2-Pfp ester
ADC Linker Cancer

NHPI-PEG4-C2-Pfp ester is used as a linker for antibody-drug conjugates (ADC).
HY-130098

Ald-Ph-amido-PEG3-C-COOH
ADC Linker Cancer

Ald-Ph-amido-PEG3-C-COOH is a noncleavable linker used for the antibody-drug conjugate (ADC).
HY-130088

Bis-PEG2-NHS ester
ADC Linker Cancer

Bis-PEG2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130087

Bis-PEG3-NHS ester
ADC Linker Cancer

Bis-PEG3-NHS ester is a nonclaevable 3-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130086

Bis-PEG4-NHS ester
ADC Linker Cancer

Bis-?PEG4-?NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).

HY-153263

(Aminooxy)acetamide-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
(Aminooxy)acetamide-Val-Cit-PAB-MMAE (MMAE 5) is an intermediate used in the synthetic preparation of drug-linker conjugates for ADC. (Aminooxy)acetamide-Val-Cit-PAB-MMAE is conjugated to polyamide via oxime bond formation to form MMAE polyamide conjugate. Then MMAE polyamide conjugate can be conjugated to Trastuzumab, to make ADC.

HY-148131

MC-Val-Cit-PABA-amide-PEG4-COOH	ADC Linker	Cancer
MC-Val-Cit-PABA-amide-PEG4-COOH is a cleavable ADC linker used in the synthesis of OMTX705. OMTX705 is a novel FAP-targeting antibody-drug conjugates (ADCs), and shows antitumor activity.

HY-136297

DGN549-C	Drug-Linker Conjugates for ADC	Cancer
DGN549-C consists a cleavable?ADC?linker valine-alanine (va) and PBD dimer. DGN549 is a novel DNA-alkylating cytotoxic payload and can be used in?the?synthesis?of?antibody-agent?conjugates?(ADCs).

HY-145078

PNU-EDA-Gly5	Drug-Linker Conjugates for ADC	Cancer
PNU-EDA-Gly5 is an oligo-glycine linker-payload for ADC synthesis, composed of a DNA topoisomerase I inhibitor PNU-159682 and a linker EDA-Gly5.

HY-128968

PEG4-aminooxy-MMAF Amberstatin; AS269	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer Inflammation/Immunology
PEG4-aminooxy-MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the potent antitubulin agent MMAF, linked via the noncleavable PEG4.

HY-128961

MC-Alkyl-Hydrazine Modified MMAF	Drug-Linker Conjugates for ADC	Cancer
MC-Alkyl-Hydrazine Modified MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the Modified MMAF (a tubulin inhibitor), linked via the noncleavable MC-Alkyl-Hydrazine.

HY-132161

MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT	Drug-Linker Conjugates for ADC	Cancer
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker compound extracted from patent WO2019195665A1, example 4-1. MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a agent-linker conjugate for antibody-drug conjugate (ADC).

HY-130185

m-PEG7-CH2CH2CHO	ADC Linker PROTAC Linkers	Cancer
m-PEG7-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W067509

m-PEG3-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
m-PEG3-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W035376

m-PEG6-CH2CH2CHO	ADC Linker PROTAC Linkers	Cancer
m-PEG6-CH2CH2CHO is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG6-CH2CH2CHO is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-130151

m-PEG7-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
m-PEG7-CH2CH2COOH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG7-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-19792

Mertansine DM1; Maytansinoid DM1	Microtubule/Tubulin ADC Cytotoxin	Cancer
Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC).

HY-139292

Fmoc-NH-PEG6-alcohol	Amino Acid Derivatives	Cancer
Fmoc-NH-PEG6-alcohol is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG6-alcohol is extracted from patent WO2016030791, example comp 91.

HY-44234A

Fmoc-Gly-Gly-D-Phe-OtBu	ADC Linker	Cancer
Fmoc-Gly-Gly-D-Phe-OtBu is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Gly-Gly-D-Phe-OtBu is the R-isomer of Fmoc-Gly-Gly-Phe-OtBu (HY-44234).

HY-130085

Mal-PEG6-NHS ester
ADC Linker Cancer

Mal-PEG6-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 6-unit PEG and a NHS ester.

HY-15740

Mc-MMAD	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
Mc-MMAD is a protective group (maleimidocaproyl)-conjugated MMAD. MMAD is a potent tubulin inhibitor. Mc-MMAD is a agent-linker conjugate for ADC.

HY-126506

Mal-PEG4-PFP ester
ADC Linker Cancer

Mal-PEG4-PFP ester is a nonclaevable ADC linker containing a Maleimide group, 4-unit PEG and a PFP ester.
HY-126504

Mal-PEG2-NHS ester
ADC Linker Cancer

Mal-PEG2-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 2-unit PEG and an NHS ester.

HY-133433

DBCO-PEG4-VA-PBD	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-VA-PBD is a agent-linker conjugate for ADC by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via DBCO-PEG4-VA.

HY-136290

Mc-Dexamethasone	Drug-Linker Conjugates for ADC	Cancer
Mc-Dexamethasone is a agent-linker conjugate for ADC. Mc-Dexamethasone is made toxin Dexamethasone (HY-14648) conjugated to the non-cleavable MC linker. Dexamethasone is a?glucocorticoid receptor?agonist.

HY-140213

Azido-PEG2-C2-amine N3-PEG2-CH2CH2NH2	PROTAC Linkers ADC Linker	Cancer
Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs).

HY-130990

DBCO-PEG4-Val-Cit-PAB-MMAF	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-Val-Cit-PAB-MMAF consists a cleavable 4 unit PEG ADC linker (DBCO-PEG4-Val-Cit-PAB) and a potent tubulin polymerization inhibitor (MMAF). DBCO-PEG4-Val-Cit-PAB-MMAF can be used in the synthesis of antibody-drug conjugates (ADCs).

HY-151740

4-Pentynoyl-Val-Ala-PAB-PNP
ADC Linker Others

4-Pentynoyl-Val-Ala-PAB-PNP is a cleavable ADC linker, that has been used to synthesis cryptophycin conjugates.
HY-130097

Ald-Ph-amido-PEG4-C2-acid
ADC Linker Cancer

Ald-Ph-amido-PEG4-C2-acid is a noncleavable linker used for the antibody-drug conjugate (ADC).
HY-112806

ST8155AA1
Drug-Linker Conjugates for ADC Cancer

ST8155AA1 is a part of antibody agent conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity.
HY-112805

ST8154AA1
Drug-Linker Conjugates for ADC Cancer

ST8154AA1 is a part of antibody agent conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity.

HY-100566

SuO-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
SuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB.

HY-130167

Fmoc-NH-PEG9-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG9-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG9-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W040238

Fmoc-NH-PEG2-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG2-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG2-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W007713

Fmoc-8-amino-3,6-dioxaoctanoic acid Fmoc-NH-PEG2-CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-NH-PEG2-CH2COOH) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-8-amino-3,6-dioxaoctanoic acid is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-129942

S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate	ADC Linker	Cancer
S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is a glutathione cleavable **ADC linker** used for the antibody-drug conjugates (ADCs) and refers to the Alkyl-Chain composition. S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is the linker portions of the molecules employed for mAb attachment purposes.

HY-W040231

Fmoc-NH-PEG3-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W000434

Fmoc-NH-PEG4-CH2CH2COOH Fmoc-15-amino-4,7,10,13-tetraoxapentadecanoic acid	ADC Linker PROTAC Linkers	Cancer
Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-NH-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-132250

MCC-DM1
Drug-Linker Conjugates for ADC Cancer

MCC-DM1 is a agent-Linker Conjugates for ADC such ad Anti-CD22-MCC-DM1.
HY-130084

Mal-PEG2-VCP-NB
ADC Linker Cancer

Mal-PEG2-VCP-NB is a claevable ADC linker containing a Maleimide group, 2-unit PEG and a VCP NB.

HY-W035378

Fmoc-N-methyl-PEG3-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
Fmoc-N-methyl-PEG3-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-N-methyl-PEG3-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-128979

Deruxtecan analog 2	Drug-Linker Conjugates for ADC	Cancer
Deruxtecan analog 2 (example 9 P3) is a Deruxtecan (HY-13631E) analog. Deruxtecan analog 2 is a *agent-linker* conjugate** composed of Camptothecin (HY-16560) and a linker. Camptothecin (CPT) is a Topo I inhibitor with antineoplastic activity against colorectal, breast, lung and ovarian cancers. Deruxtecan analog 2 can be used for the preparation anti-FGFR2 ADC.

HY-139642

Mal-(CH2)5-Val-Cit-PAB-Eribulin	Drug-Linker Conjugates for ADC	Cancer
Mal-(CH2)5-Val-Cit-PAB-Eribulin is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-microtubule agent, Eribulin, linked via linker Mal-(CH2)5-Val-Cit-PAB.

HY-141147

7-O-(Amino-PEG4)-paclitaxel	Drug-Linker Conjugates for ADC	Cancer
7-O-(Amino-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Amino-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs).

HY-P1449

Boc-Gly-Gly-Phe-Gly-OH	ADC Linker	Cancer
Boc-Gly-Gly-Phe-Gly-OH, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate *(ADC)*.

HY-100567

MAL-di-EG-Val-Cit-PAB-MMAE
Drug-Linker Conjugates for ADC Cancer

MAL-di-EG-Val-Cit-PAB-MMAE consists the ADCs linker (MAL-di-EG-Val-Cit-PAB) and potent tubulin inhibitor (MMAE).

HY-15741

Mc-MMAE Maleimidocaproyl-monomethylauristatin E	Microtubule/Tubulin Drug-Linker Conjugates for ADC	Cancer
Mc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a agent-linker conjugate for ADC.

HY-79369

Succinic anhydride	ADC Linker	Cancer
Succinic anhydride is a cyclic anhydride and a nonclaevable **ADC linker** extracted from patent WO2009064913A1. Succinic anhydride can react with compound 4 of the patent to link the proagent to an amine or hydroxy 1 group of a targeting polypeptide.

HY-15575

VcMMAE MC-Val-Cit-PAB-MMAE; mc-vc-PAB-MMAE	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
VcMMAE (mc-vc-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).

HY-42490

N3-PEG3-CH2CH2COOH	PROTAC Linkers ADC Linker	Cancer Inflammation/Immunology
N3-PEG3-CH2CH2COOH a PEG-based PROTAC linker can be used in the synthesis of BI-3663 (HY-111546), BI-4216 and BI-0319. Azido-PEG3-acid is also a non-cleavable 3 unit PEG *ADC* linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-W021787

NH2-PEG4-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
NH2-PEG4-CH2CH2COOH is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG4-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-126684

Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA is a agent-linker conjugate for *ADC* by using the antitumor antibiotic, Duocarmycin SA, linked via Mal-PEG4-VC-PAB-DMEA-Seco.

HY-W190943

Azido-PEG4-Val-Cit-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
Azido-PEG4-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the cleavable linker Azido-PEG4-Val-Cit-PAB-OH.

HY-P1449A

Boc-Gly-Gly-Phe-Gly-OH TFA	ADC Linker	Cancer
Boc-Gly-Gly-Phe-Gly-OH TFA, a self-assembly of N- and C-protected tetrapeptide, is a protease cleavable linker used for the antibody-drug conjugate *(ADC)*.

HY-W018811S

N-Pyrazinylcarbonylphenylalanine-d8	Isotope-Labeled Compounds	Others
N-Pyrazinylcarbonylphenylalanine-d₈ is the deuterium labeled Deruxtecan. Deruxtecan is an ADC agent-linker conjugate composed of a derivative of DX-8951 (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

HY-148380A

Mal-PEG8-Phe-Lys-PAB-Exatecan TFA	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG8-Phe-Lys-PAB-Exatecan TFA is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631).

HY-W008352

Boc-NH-PEG4-CH2CH2NH2	ADC Linker PROTAC Linkers	Cancer
Boc-NH-PEG4-CH2CH2NH2 a cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-NH-PEG4-CH2CH2NH2 is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-W040257

NH2-PEG6-CH2CH2COOH	ADC Linker PROTAC Linkers	Cancer
NH2-PEG6-CH2CH2COOH is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). NH2-PEG6-CH2CH2COOH is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

HY-141148

7-O-(Cbz-N-amido-PEG4)-paclitaxel	Drug-Linker Conjugates for ADC	Cancer
7-O-(Cbz-N-amido-PEG4)-paclitaxel is a PEG-class Drug-linker conjugates for ADC, containing a paclitaxel moiety and a amino group. The amine group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. 7-O-(Cbz-N-amido-PEG4)-paclitaxel can be used in the synthesis of Antibody-Drug Conjugates (ADCs).

HY-130103

Ald-Ph-amido-PEG2-C2-Pfp ester
ADC Linker Cancer

Ald-Ph-amido-PEG2-C2-Pfp ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130106

Ald-Ph-amido-PEG1-C2-NHS ester
ADC Linker Cancer

Ald-Ph-amido-PEG1-C2-NHS ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130104

Ald-Ph-amido-PEG2-C2-NHS ester
ADC Linker Cancer

Ald-Ph-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).
HY-101159

Mal-amido-PEG8-C2-acid
ADC Linker Cancer

Mal-amido-PEG8-C2-acid (example 142) is a nonclaevable ADC linker, extracted from patent US2018339985.
HY-126510

MC-PEG2-C2-NHS ester
ADC Linker Cancer

MC-PEG2-C2-?NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130094

NHPI-PEG2-C2-Pfp ester
ADC Linker Cancer

NHPI-PEG2-C2-Pfp ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130105

Ald-Ph-amido-PEG1-C2-Pfp ester
ADC Linker Cancer

Ald-Ph-amido-PEG1-C2-Pfp ester is a nonclaevable 1-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130095

NHPI-PEG2-C2-NHS ester
ADC Linker Cancer

NHPI-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130101

Ald-Ph-amido-PEG4-C2-NHS ester
ADC Linker Cancer

Ald-Ph-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).
HY-130092

NHPI-PEG3-C2-Pfp ester
ADC Linker Cancer

NHPI-PEG3-C2-Pfp ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130093

NHPI-PEG3-C2-NHS ester
ADC Linker Cancer

NHPI-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-112786

MC-Val-Cit-PAB-MMAF Vc-MMAF	Drug-Linker Conjugates for ADC	Cancer
MC-Val-Cit-PAB-MMAF (Vc-MMAF) is a agent-linker conjugate for ADC by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. MC-Val-Cit-PAB-MMAF shows antitumor activity.

HY-101152

SG3199-Val-Ala-PAB	Drug-Linker Conjugates for ADC	Cancer
SG3199-Val-Ala-PAB is an intermediate of Tesirine synthesis. Tesirine is a agent-linker conjugate for ADC which can be used for the research of several cancers.

HY-126669

Mal-PEG4-VA
ADC Linker Cancer

Mal-PEG4-VA is a cleavable ADC linker containing a Maleimide group. Mal-PEG4-VA is used for making antibody-drug conjugate.

HY-141604

Glembatumumab vedotin CDX-011; CR011-vcMMAE	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Glembatumumab vedotin (CDX-011) is an *ADC* (antibody-drug conjugates (ADCs)) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects.

HY-148380

Mal-PEG8-Phe-Lys-PAB-Exatecan	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG8-Phe-Lys-PAB-Exatecan (compound 15) is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan (HY-13631) composition.

HY-150230

Desthiobiotin-Iodoacetamide	ADC Linker	Others
Desthiobiotin-Iodoacetamide can be used as an **ADC Linker**. Desthiobiotin-Iodoacetamide also acts as a probe used to label the the Oridonin (HY-N0004)-treated cell lysis.

HY-115524

DBCO-NHS ester 2	ADC Linker	Cancer
DBCO-NHS ester 2 is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 2 is a derivative of Dibenzylcyclooctyne (DBCO) used in copper-free click chemistry.

HY-130648

Thalidomide-NH-PEG7	Drug-Linker Conjugates for ADC E3 Ligase Ligand-Linker Conjugates	Cancer
Thalidomide-NH-PEG7 is a synthesized E3 ligase ligand-linker conjugate for *ADC. Thalidomide-NH-PEG7 can be connected to the ligand for protein by a linker* to form PROTAC iRucaparib-AP6, a highly specific PARP1 degrader.

HY-131088

N3-PEG8-Phe-Lys-PABC-Gefitinib	Drug-Linker Conjugates for ADC	Cancer
N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC.

HY-129359

PDP-Pfp
ADC Linker Cancer

PDP-Pfp is a reducible ADC linker used for the agents that target for the extracellular loop 1 (ECL1) of TM4SF1 (transmembrane 4 L6 family member 1).
HY-126529

N3-PEG3-C2-PFP ester
ADC Linker Cancer

N3-PEG3-C2-PFP ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130108

N3-PEG4-C2-Pfp ester
ADC Linker Cancer

N3-PEG4-C2-Pfp ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-137883

Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br	ADC Linker	Cancer
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br is an ADC linker that can be used to synthesize ABBV-154, ABBV-927, ABBV-368 or their analogs.

HY-126527

N3-PEG2-C2-PFP ester
ADC Linker Cancer

N3-PEG2-C2-PFP ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-129526

Mal-PEG3-NHS ester
ADC Linker Cancer

Mal-PEG3-NHS ester is a noncleavable ADC linker containing a Maleimide group. Mal-PEG3-NHS ester is used for making antibody-drug conjugate.
HY-126528

N3-PEG3-C2-NHS ester
ADC Linker Cancer

N3-PEG3-C2-NHS ester is a nonclaevable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-126526

N3-PEG2-C2-NHS ester
ADC Linker Cancer

N3-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).
HY-130109

N3-PEG4-C2-NHS ester
ADC Linker Cancer

N3-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs).

HY-114816

N-Butanoyl-L-homoserine lactone C4-HSL; N-Butyryl-L-homoserine lactone	ADC Linker Bacterial	Infection Inflammation/Immunology
N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable **ADC linker** used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa.

HY-126514

Propargyl-O-C1-amido-PEG2-C2-NHS ester
ADC Linker Cancer

Propargyl-O-C1-amido-PEG2-C2-NHS ester is a nonclaevable 2-unit PEG linker for antibody-agent-conjugation (ADC).

HY-128871

VCP-Eribulin	Drug-Linker Conjugates for ADC	Cancer
VCP-Eribulin consists the ADCs linker (VCP) and Eribulin. Eribulin is a mechanistically unique microtubule inhibitor for cancer. VCP-Eribulin is an Eribulin-based agent for antibody conjugates.

HY-126515

Propargyl-O-C1-amido-PEG4-C2-NHS ester
ADC Linker Cancer

Propargyl-O-C1-amido-PEG4-C2-NHS ester is a nonclaevable 4-unit PEG linker for antibody-agent-conjugation (ADC).

HY-128711

MAL-di-EG-Val-Cit-PAB-MMAF	Drug-Linker Conjugates for ADC	Cancer
MAL-di-EG-Val-Cit-PAB-MMAF consists the ADCs linker (MAL-di-EG-Val-Cit-PAB) and potent tubulin polymerization blocker (MMAF, Monomethyl auristatin F).

HY-79369S

Succinic anhydride-d4	Isotope-Labeled Compounds ADC Linker	Cancer
Succinic anhydride-d₄ is the deuterium labeled Succinic anhydride. Succinic anhydride is a cyclic anhydride and a nonclaevable ADC linker extracted from patent WO2009064913A1. Succinic anhydride can react with compound 4 of the patent to link the proagent to an amine or hydroxy 1 group of a targeting polypeptide[1].

HY-W017389S

Xanthine-13C,15N2	Drug-Linker Conjugates for ADC	Cancer
Xanthine-¹³C,¹⁵N₂ is a ¹⁵N-labeled and ¹³C-labled Deruxtecan. Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

HY-W002327S1

L-Asparagine-N-Fmoc,N-beta-trityl-15N2	Isotope-Labeled Compounds Drug-Linker Conjugates for ADC	Cancer
L-Asparagine-N-Fmoc,N-beta-trityl-¹⁵N₂ is a ¹⁵N-labeled Deruxtecan. Deruxtecan is an ADC agent-linker conjugate composed of a derivative of DX-8951 (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

HY-147271

Mal-PEG8-Val-Ala-PAB-Exatecan	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC *linker) that binds to Nectin-4* polypeptides conjugated to chemotherapeutic agents. Mal-PEG8-Val-Ala-PAB-Exatecan can be used for cancer research.

HY-100874

N3-PEG3-vc-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
N3-PEG3-vc-PAB-MMAE is a synthesized agent-linker conjugate for ADC that incorporates the MMAE (a tubulin inhibitor ) and 3-unit PEG linker. N3-PEG3-vc-PAB-MMAE shows potent antitumor activity.

HY-148067

XMT-1519 conjugate-1	ADC Linker	Cancer
ΧΜΤ-1519 conjugate-1 (compound 31) is a linker for the HER-2 monoclonal antibody XMT-1519, which can be used to synthesize ADC and increase anti-tumor activity.

HY-148424

PBD dimer-2	Others	Cancer
PBD dimer-2 (compound 2c) is a C8-linked pyrrolobenzodiazepine dimer. PBD dimer-2 can span an extra base pair and cross-link the 5′-Pu-GA(T/A)TC-Py sequence. PBD dimer-2 can be used as a payload for antibody–agent conjugates (ADCs), and it can be used for the research of cancer.

HY-136291

Sulfo-SPDB-DGN462	Drug-Linker Conjugates for ADC	Cancer
Sulfo-SPDB-DGN462 is a agent-linker conjugate for ADC. Sulfo-SPDB-DGN462 consists a toxin DGN462 (HY-101150) conjugated to the cleavable Sulfo-SPDB linker. DGN462, a potent?DNA-alkylating?agent, shows anti-tumor activity, such as acute myeloid leukemia (AML).

HY-79369S1

Succinic anhydride-13C2	ADC Linker	Cancer
Succinic anhydride-¹³C₂ is the ¹³C labeled Succinic anhydride[1]. Succinic anhydride is a cyclic anhydride and a nonclaevable ADC linker extracted from patent WO2009064913A1. Succinic anhydride can react with compound 4 of the patent to link the proagent to an amine or hydroxy 1 group of a targeting polypeptide[2].

HY-126671

Mal-Phe-C4-Val-Cit-PAB	ADC Linker	Cancer
Mal-Phe-C4-Val-Cit-PAB is a cleavable ADC linker containing a Maleimide group. Mal-Phe-C4-Val-Cit-PAB is used for making antibody-drug conjugate.

HY-151709

N3-L-Cit-OH	ADC Linker	Others
N3-L-Cit-OH is a click chemistry reagent containing an azide group. N3-L-Cit-OH can be used to construct peptidomimetic ADC linkers using Click-chemistry.

HY-148668A

MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan	Topoisomerase Drug-Linker Conjugates for ADC	Cancer
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan (HY-13631). Exatecan is a DNA Topoisomerase I inhibitor (IC₅₀=2.2 μM).

HY-129372

PDdB-Pfp
ADC Linker Cancer

PDdB-Pfp is a cleavable ADC linker used for the agents that target for the extracellular loop 1 (ECL1) of TM4SF1 (transmembrane 4 L6 family member 1).

HY-148668

MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan (HY-13631). Exatecan is a DNA Topoisomerase I inhibitor (IC₅₀=2.2 μM).

HY-136170

MC-SN38	Drug-Linker Conjugates for ADC	Cancer
MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA synthesis and causes frequent DNA single-strand breaks.

HY-126674

Mal-Phe-C4-Val-Cit-PAB-DMEA	ADC Linker	Cancer
Mal-Phe-C4-Val-Cit-PAB-DMEA is a cleavable ADC linker containing a Maleimide group. Mal-Phe-C4-Val-Cit-PAB-DMEA is used for making antibody-drug conjugate.

HY-151709A

N3-L-Cit-OH (DCHA)	ADC Linker	Others
N3-L-Cit-OH DCHA is a click chemistry reagent containing an azide group. N3-L-Cit-OH DCHA can be used to construct peptidomimetic ADC linkers using Click-chemistry.

HY-126673

Mal-C2-Gly3-EDA
ADC Linker Cancer

Mal-C2-Gly3-EDA is a cleavable ADC linker containing a Maleimide group. Mal-C2-Gly3-EDA is used for making antibody-drug conjugate.

HY-P99967

Cantuzumab	ADC Antibody	Cancer
Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493).

HY-112100

PAC	Estrogen Receptor/ERR PROTAC-Linker Conjugates for PAC	Cancer
PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab).

HY-148326

Glu(OtBu)-Val-Cit-PAB-OH	ADC Linker	Others
Glu(OtBu)-Val-Cit-PAB-OH (compound L5-1c) is an non-cleavable **ADC linker**. Glu(OtBu)-Val-Cit-PAB-OH has been used to synthesis protein-tubulysin conjugates.

HY-136314

DBCO-PEG4-VC-PAB-MMAE	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-VC-PAB-MMAE consists a?ADC?linker (DBCO-PEG4-VC-PAB) and a tubulin?polymerization inhibitor MMAE (HY-15162). DBCO-PEG4-VC-PAB-MMAE can be used in?the?synthesis?of?antibody-agent?conjugates?(ADCs). MMAE is a synthetic derivative of dolastatin 10 and functions as a potent?mitotic?inhibitor by inhibiting?tubulin polymerization.

HY-114816S

N-butyryl-L-Homoserine lactone-d5	Isotope-Labeled Compounds ADC Linker Bacterial	Infection Inflammation/Immunology
N-butyryl-L-Homoserine lactone-d₅ is the deuterium labeled N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone (C4-HSL) is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm[1]. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa[2][3].

HY-128952

Tesirine SG3249	Drug-Linker Conjugates for ADC DNA Alkylator/Crosslinker	Cancer
Tesirine (SG3249) is an antibody-drug conjugate (ADC) pyrrolobenzodiazepine (PBD) dimer payload. Tesirine combines potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. SG3199 (HY-101161) is the released warhead component of the ADC payload Tesirine. SG3199 retains picomolar activity in a panel of cancer cell lines. PBD dimers are highly efficient DNA minor groove cross-linking agents with potent cytotoxicity.

HY-W040289

Mal-amido-PEG2-NHS ester	ADC Linker	Cancer
Mal-amido-PEG2-NHS ester is a nonclaevable *ADC* linker containing a maleimide group and an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules.

HY-115545

DBCO-NHS ester 3	ADC Linker	Cancer
DBCO-NHS ester 3 (Compound 12) is a cleavable linker that is used for making antibody-drug conjugate (ADC). DBCO-NHS ester 3 is a derivative of Dibenzylcyclooctyne (DBCO) obtained by activation of N-hydroxysuccinimide by the carboxylic acid moiety of both methyl-oxanorbornadiene (MeOND) and dibenzoazacyclooctyne (DIBAC).

HY-101982

Lys-SMCC-DM1 Lys-Nε-MCC-DM1	Drug-Linker Conjugates for ADC	Cancer
Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is a agent-linker conjugates for ADC that can inhibit tubulin polymerization. Lys-SMCC-DM1 is the active metabolite of T-DM1. T-DM1 is a HER2-targeting ADC with a tubulin polymerization inhibitor DM1. Lys-SMCC-DM1 can be used in the research of breast cancer.

HY-113764

N-Butanoyl-DL-homoserine lactone (Rac)-C4-HSL	Bacterial	Infection Inflammation/Immunology
N-Butanoyl-DL-homoserine lactone ((Rac)-C4-HSL) is a racemic mixture of N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa.

HY-136261

DM1-PEG4-DBCO	Drug-Linker Conjugates for ADC	Cancer
DM1-(PEG)4-DBCO is a agent-linker conjugate composed of a potent microtubulin?inhibitor?DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a?microtubulin?inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery.

HY-136260

DBCO-PEG4-Ahx-DM1	Drug-Linker Conjugates for ADC	Cancer
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin?inhibitor?DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a?microtubulin?inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery.

HY-124386

DBCO-NHCO-PEG4-amine	ADC Linker PROTAC Linkers	Cancer
DBCO-NHCO-PEG4-amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. DBCO-NHCO-PEG4-amine is a cleavable **ADC linker** used to conjugate MMAE (HY-15162) and antibody (e.g., DBCO-VCpAB−MMAE and DBCO-TRX−MMAE with EC₅₀s of 280 nM and 22 nM in SKBR3 cells, respectively).

HY-15578

McMMAF Maleimidocaproyl monomethylauristatin F	Drug-Linker Conjugates for ADC	Cancer
McMMAF is a protective group (maleimidocaproyl)-conjugated MMAF, which is a potent tubulin polymerization inhibitor. McMMAF can be used as a agent-linker for antibody-drug conjugates (ADC). McMMAF is uncleavable, and must be internalized and degraded within a cell, releasing cysteine-McMMAF as the active agent.

HY-P99734

Mipasetamab uzoptirine ADCT-601	TAM Receptor	Cancer
Mipasetamab uzoptirine (ADCT-601) is an AXL-targeted antibody-drug conjugates (ADCs). Mipasetamab uzoptirine consists of a humanized anti-AXL antibody, a cleavable linker and the potent pyrrolobenzodiazepine (PBD) dimer cytotoxin SG3199. Mipasetamab uzoptirine can be used for the research of cancers.

HY-145663

HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM	Drug-Linker Conjugates for ADC	Cancer
HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM is a agent-linker (peptide-cleavable) conjugate for ADC. DM indicates the maytansinoid moiety.

HY-126509

Mal-amido-PEG10-C2-NHS ester	ADC Linker	Cancer
Mal-amido-PEG10-C2-NHS ester is a nonclaevable *ADC* linker containing a maleimide group and an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules.

HY-126508

Mal-amido-PEG5-C2-NHS ester	ADC Linker	Cancer
Mal-amido-PEG10-C2-NHS ester is a nonclaevable *ADC* linker containing a maleimide group and an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules

HY-P9985

Disitamab vedotin RC48	Antibody-Drug Conjugates (ADCs) EGFR	Cancer
Disitamab vedotin (RC48) is an antibody-drug conjugate *(ADC)* comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE). Disitamab vedotin enhances antitumor immunity.

HY-126507

Mal-amido-PEG1-C2-NHS ester	ADC Linker	Cancer
Mal-amido-PEG1-C2-NHS ester is a nonclaevable *ADC* linker containing a maleimide group and an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules

HY-126975

Propargyl-PEG3-acid	ADC Linker PROTAC Linkers	Cancer Inflammation/Immunology
Propargyl-PEG3-acid is a non-cleavable (3 unit PEG) ADC linker and also a PEG-based PROTAC linker that can be used to synthesis 6-OHDA-PEG3-yne. 6-OHDA-PEG3-yne contains 6-OHDA (HY-B1081, HY-B1081A) and Propargyl-PEG3-acid.

HY-136313

MC-VC-PAB-Tubulysin M	Drug-Linker Conjugates for ADC	Cancer
MC-vc-PAB-Tubulysin M consists a cleavable ADC linker (MC-vc-PAB) and a cytotoxic tubulin inhibitor Tubulysin M (HY-N7053). Tubulysin M is a cytotoxic activity tubulysin which inhibits tubulin polymerization and leads to cell cycle arrest and apoptosis.

HY-P99681

Labetuzumab govitecan IMMU 130; hMN-14-SN-38	Antibody-Drug Conjugates (ADCs)	Cancer
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer.

HY-P99264

Inotuzumab Humanized Anti-CD22 Recombinant Antibody	ADC Antibody CD22	Cancer
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma.

HY-128946

CL2A-SN-38	Drug-Linker Conjugates for ADC	Cancer Inflammation/Immunology
CL2A-SN-38 is a *agent-linker* conjugate** composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects.

HY-128870

Mal-PEG2-VCP-Eribulin	Drug-Linker Conjugates for ADC	Cancer
Mal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin. Eribulin is a mechanistically unique microtubule inhibitor for cancer. Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugates.

HY-130081

DM3-SMe	ADC Cytotoxin Microtubule/Tubulin	Cancer
DM3-SMe is a maytansine derivative and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM3-SMe shows highly cytotoxic activity in vitro with an IC₅₀ of 0.0011 nM.

HY-128527

PROTAC ER Degrader-3	PROTACs Estrogen Receptor/ERR	Cancer
PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab).

HY-141662

2',3'-cGAMP-C2-PPA	STING Drug-Linker Conjugates for ADC	Cancer
2',3'-cGAMP-C2-PPA (45), A cyclic di-nucleotide, is a STING agonist (US20210015941A1). 2',3'-cGAMP-C2-PPA is a agent-linker conjugate for ADC that can be used in synthesis of antibody-drug conjugates for the targeted treatment of cancer.

HY-128528

PROTAC ER Degrader-2	PROTACs Estrogen Receptor/ERR	Cancer
PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab).

HY-145943

MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT	Drug-Linker Conjugates for ADC	Cancer Inflammation/Immunology
MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT is a?agent-linker conjugate for antibody-drug conjugate (ADC). MP-PEG8-Val-Lys-Gly-7-MAD-MDCPT has?the?potential?for?cancer and autoimmune disease?research.

HY-P99813

Patritumab deruxtecan HER3-DXd; U3-1287	Antibody-Drug Conjugates (ADCs)	Cancer
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity.

HY-130082

DM4-SMe	ADC Cytotoxin Microtubule/Tubulin	Cancer
DM4-SMe is a metabolite of antibody-maytansin conjugates (AMCs) and a tubulin inhibitor, and also a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM4-SMe inhibits KB cells with an IC₅₀ of 0.026 nM.

HY-P99493

Cantuzumab ravtansine IMGN242; huC242-DM4	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Cantuzumab ravtansine (IMGN242; huC242-DM4), an *ADC, is a humanized monoclonal antibody, huC242, covalently linked* via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.

HY-153360

MC-GGFG-AM-(10Me-11F-Camptothecin)	Drug-Linker Conjugates for ADC Topoisomerase	Cancer
MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells.

HY-148875

Py-MAA-Val-Cit-PAB-MMAE AAJ8D6-PY-Val-Cit-MMAE	ADC Linker	Cancer
Py-MAA-Val-Cit-PAB-MMAE (AAJ8D6-PY-Val-Cit-MMAE) is an **ADC Linker of Zapadcine-3a. Zapadcine-3a is an anti-TRAILR2** ADC with broad spectrum, and antineoplastic effect. Zapadcine-3a can be swallowed up into lysosome of tumor cells by binding to TRAILR2. Then Zapadcine-3a releases small molecular compound to specifically kill various TRAILR2-pos. Zapadcine-3a potently eradicates tumor cells and cures tumor.

HY-112099

Mc-Val-Cit-PAB-Cl	ADC Linker	Cancer
Mc-Val-Cit-PAB-Cl is a cleavable ADC linker. Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE with IC₅₀s of 3.3 and 0.95 nM for BJAB and WSU cell lines in cytotoxicity assay).

HY-138298A

Trastuzumab deruxtecan DS-8201; DS-8201a	Antibody-Drug Conjugates (ADCs) EGFR	Cancer
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.

HY-138298

Trastuzumab deruxtecan (solution) DS-8201 (solution); DS-8201a (solution)	Antibody-Drug Conjugates (ADCs) EGFR	Cancer
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.

HY-P99612

Farletuzumab ecteribulin MORAb-202	Antibody-Drug Conjugates (ADCs)	Cancer
Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab?(HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.

Cat. No.	Product Name

HY-L023

Toxins for Antibody-Drug Conjugate Research Library

57 compounds

Antibody-Drug Conjugates (ADCs), a new class of treatment for cancer, are composed with a monoclonal antibody, a linker and a cytotoxic agent also referred to as a payload. To date, several ADCs have received market approval and more than 60 ADCs are currently in clinical trials. ADCs are one of the fastest growing classes of oncology drugs worldwide.

The payload or cytotoxic agent is the most important unit in the ADC. ADC has the capability to kill cancer cell depending on the potency of the payload. MCE provides 57 highly potent cytotoxins that contain auristatin derivatives, maytansinoids, calicheamicin, duocarmycin, pyrrolobenzodiazepines (PBDs), etc.

Cat. No.	Product Name	Target	Research Area

HY-136432

Mc-Gly-Gly-Phe-Gly-PAB-OH
Mc-GGFG-PAB-OH
ADC Linker Cancer

Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) is a cleavable ADC linker used for antibody-drug conjugates (ADCs).
HY-136432A

Mc-Gly-Gly-Phe-Gly-PAB-OH TFA
Mc-GGFG-PAB-OH TFA
ADC Linker Cancer

Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) TFA is a cleavable ADC linker used for antibody-drug conjugates (ADCs).